<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">101217</article-id>
<article-id pub-id-type="doi">10.7554/eLife.101217</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.101217.2</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.4</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Microbiology and Infectious Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A bacterial regulatory uORF senses multiple classes of ribosome-targeting antibiotics</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baniulyte</surname>
<given-names>Gabriele</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wade</surname>
<given-names>Joseph T</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
<email>joseph.wade@health.ny.gov</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012zs8222</institution-id><institution>Department of Biomedical Sciences, School of Public Health, University at Albany, SUNY</institution></institution-wrap>, <city>Rensselaer</city>, <country country="US">United States</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04hf5kq57</institution-id><institution>Wadsworth Center, New York State Department of Health</institution></institution-wrap>, <city>Albany</city>, <country country="US">United States</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012zs8222</institution-id><institution>RNA Institute, University at Albany, SUNY</institution></institution-wrap>, <city>Albany</city>, <country country="US">United States</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Hinnebusch</surname>
<given-names>Alan G</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution>
</institution-wrap>
<city>Bethesda</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Ron</surname>
<given-names>David</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Cambridge</institution>
</institution-wrap>
<city>Cambridge</city>
<country>United Kingdom</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-09-04">
<day>04</day>
<month>09</month>
<year>2024</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2025-04-24">
<day>24</day>
<month>04</month>
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP101217</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-07-09">
<day>09</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-07-02">
<day>02</day>
<month>07</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/682021"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2024-09-04">
<day>04</day>
<month>09</month>
<year>2024</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.101217.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.101217.1.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.101217.1.sa0">Reviewer #3 </self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.101217.1.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.101217.1.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.101217.1.sa4">Author Response:</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Baniulyte &amp; Wade</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Baniulyte &amp; Wade</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-101217-v2.pdf"/>
<abstract>
<title>Abstract</title><p>Expression of many bacterial genes is regulated by <italic>cis</italic>- and <italic>trans</italic>-acting elements in their 5’ upstream regions (URs). <italic>Cis</italic>-acting regulatory elements in URs include upstream ORFs (uORF), short ORFs that sense translation stress that manifests as ribosomes stalling at specific codons within the uORF. Here, we show that the transcript encoding the <italic>Escherichia coli</italic> TopAI-YjhQ toxin-antitoxin system is regulated by a uORF that we name “<italic>toiL</italic>”. We propose that in the absence of translation stress, a secondary structure in the UR represses translation of the <italic>topAI</italic> transcript by occluding the ribosome-binding site. Translation repression of <italic>topAI</italic> leads to premature Rho-dependent transcription termination within the <italic>topAI</italic> ORF. At least five different classes of ribosome-targeting antibiotics relieve repression of <italic>topAI</italic>. Our data suggest that these antibiotics function by stalling ribosomes at different positions within <italic>toiL</italic>, thereby altering the RNA secondary structure around the <italic>topAI</italic> ribosome-binding site. Thus, <italic>toiL</italic> is a multipurpose uORF that can respond to a wide variety of translation stresses.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Changes have been made in response to reviewer's comments following submission to eLife</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Expression of many bacterial genes is regulated by elements in their upstream regions (URs) (<xref ref-type="bibr" rid="c1">Adams et al., 2021</xref>). UR RNA can contain binding sites for <italic>trans</italic>-acting factors such as regulatory RNAs or RNA-binding proteins. UR RNAs can also include <italic>cis</italic>-acting elements, such as sequences that form secondary structures, and short ORFs (sORFs) known as upstream ORFs (uORFs). Regulatory elements in URs can modulate transcription termination within the UR, RNase accessibility within the UR, or translation initiation of the downstream gene.</p>
<p>uORFs are typically &lt;50 codons in length, and sense translational stress to regulate expression of the downstream gene. Environmental perturbations promote ribosome stalling within uORFs, often in a sequence-specific manner (<xref ref-type="bibr" rid="c64">Ramu et al., 2009</xref>); stalled ribosomes alter the UR RNA secondary structure, modulating the formation of transcription terminators, the accessibility of the ribosome binding site for the downstream gene, or loading sites for the Rho transcription termination factor. Ribosome stalling within uORFs can be mediated by limiting concentrations of charged tRNAs (<xref ref-type="bibr" rid="c40">Landick and Yanofsky, 1987</xref>), or by small molecules that bind the translating ribosomes, including amino acids and antibiotics (reviewed by (<xref ref-type="bibr" rid="c72">Seip and Innis, 2016</xref>)).</p>
<p>Translation repression mediated by regulatory elements in URs can lead to an additional level of repression at the level of transcription termination (<xref ref-type="bibr" rid="c1">Adams et al., 2021</xref>; <xref ref-type="bibr" rid="c7">Baniulyte et al., 2017</xref>; <xref ref-type="bibr" rid="c8">Bastet et al., 2017</xref>; <xref ref-type="bibr" rid="c12">Bossi et al., 2012</xref>; <xref ref-type="bibr" rid="c94">Yakhnin et al., 2001</xref>). This occurs because Rho-dependent transcription termination is inhibited by translation (<xref ref-type="bibr" rid="c2">Adhya and Gottesman, 1978</xref>; <xref ref-type="bibr" rid="c65">Richardson, 2002</xref>). Reduced translation mediated by regulatory elements in URs allows Rho to load onto Rho utilization (Rut) sequences in the nascent RNA for the ORF that would otherwise be occluded by ribosomes. Ruts are enriched for ‘YC’ dinucleotides, lack extensive secondary structure, and have a high C:G ratio (<xref ref-type="bibr" rid="c3">Alifano et al., 1991</xref>; <xref ref-type="bibr" rid="c55">Nadiras et al., 2018</xref>; <xref ref-type="bibr" rid="c66">Rivellini et al., 1991</xref>; <xref ref-type="bibr" rid="c68">Schneider et al., 1993</xref>). The relatively low information content required for a Rut means that many sequences within ORFs can function as a Rut when translation is repressed. Translating ribosomes may also inhibit Rho termination by preventing association of Rho with RNA polymerase (RNAP) and the associated transcription elongation factor NusG (<xref ref-type="bibr" rid="c15">Burmann et al., 2010</xref>).</p>
<p>Genome-wide studies of transcription termination <italic>Escherichia coli</italic> and <italic>Mycobacterium tuberculosis</italic> have identified many Rho termination events within ORFs (<xref ref-type="bibr" rid="c1">Adams et al., 2021</xref>; <xref ref-type="bibr" rid="c17">Cardinale et al., 2008</xref>; <xref ref-type="bibr" rid="c20">Dar and Sorek, 2018</xref>; <xref ref-type="bibr" rid="c25">D’Halluin et al., 2022</xref>; <xref ref-type="bibr" rid="c62">Peters et al., 2012</xref>, <xref ref-type="bibr" rid="c63">2009</xref>), suggesting that modulation of premature Rho termination is a widespread regulatory mechanism. Here, we characterize the mechanism of regulated Rho termination within the <italic>E. coli topAI</italic> gene that is operonic with two additional genes, <italic>yjhQ</italic> and <italic>yjhP</italic> (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) (<xref ref-type="bibr" rid="c49">Mao et al., 2015</xref>). The <italic>topAI</italic> and <italic>yjhQ</italic> genes encode a type II toxin-antitoxin system, where <italic>topAI</italic> encodes a topoisomerase A inhibitor, and <italic>yjhQ</italic> encodes the cognate antitoxin (<xref ref-type="bibr" rid="c96">Yamaguchi and Inouye, 2015</xref>). We show that Rho-dependent transcription termination within <italic>topAI</italic> is a consequence of translation repression. We further show that the long 5′ UR of <italic>topAI</italic> encodes a regulatory uORF, <italic>toiL</italic> (<xref rid="fig1" ref-type="fig">Figure 1A</xref>), that acts as a sensor for translation stress caused by multiple classes of ribosome-targeting antibiotics. We propose that these antibiotics promote ribosome stalling at various sites within <italic>toiL</italic>, and that ribosome stalling anywhere within <italic>toiL</italic> unmasks the ribosome binding site of <italic>topAI</italic>. Thus, <italic>toiL</italic> is a multipurpose regulatory uORF that can sense a wide variety of translational stresses.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Rho-dependent transcription termination within the <italic>topAI</italic> gene.</title>
<p><bold>(A)</bold> Schematic representation of the <italic>E. coli topAI</italic>-<italic>yjhQ</italic>-<italic>yjhP</italic> operon, including the <italic>toiL</italic> uORF. <bold>(B)</bold> Schematic representation of <italic>topAI</italic>-<italic>lacZ</italic> transcriptional reporter fusions, indicating the position of the transcription start site (TSS) with respect to the <italic>topAI</italic> start codon, and the mutation in the putative <italic>rut</italic>. <bold>(C)</bold> β-galactosidase activity of <italic>topAI</italic>-<italic>lacZ</italic> transcriptional fusions in wild-type (strain AMD054) or <italic>rho</italic> mutant (R66S amino acid substitution in Rho; strain GB004) cells. Reporter fusions with wild-type sequence or mutation of the predicted <italic>rut</italic> (<italic>rut</italic>*) extend to position +42 or +10 of <italic>topAI</italic> (wild-type +42, plasmid pGB217; wild-type +10, plasmid pGB215; <italic>rut</italic>* +42, plasmid pGB306; <italic>rut</italic>* +10, plasmid pGB305). Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Translational repression of <italic>topAI</italic> leads to intragenic Rho-dependent transcription termination</title>
<p>Genome-scale analysis of Rho termination identified a putative termination site in the coding region of <italic>topAI</italic> (<xref ref-type="bibr" rid="c1">Adams et al., 2021</xref>; <xref ref-type="bibr" rid="c62">Peters et al., 2012</xref>). The <italic>topAI</italic> transcript has an unusually long UR (171 nt) (<xref ref-type="bibr" rid="c83">Thomason et al., 2015</xref>), suggesting that Rho termination within <italic>topAI</italic> may be regulated by sequences in the UR. To independently assess whether Rho prematurely terminates <italic>topAI</italic> transcription, we constructed a <italic>lacZ</italic> transcriptional reporter fusion that included the <italic>topAI</italic> promoter and UR, and 42 nt of the <italic>topAI</italic> coding region (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). We measured expression of this reporter fusion in wild-type cells and cells expressing the R66S Rho mutant that is defective for RNA binding and termination (<xref ref-type="bibr" rid="c7">Baniulyte et al., 2017</xref>; <xref ref-type="bibr" rid="c50">Martinez et al., 1996</xref>). We observed ∼7-fold higher expression in <italic>rho</italic> mutant cells than in wild-type cells (<xref rid="fig1" ref-type="fig">Figure 1C</xref>), consistent with a Rho termination site upstream of position 42 of the <italic>topAI</italic> gene.</p>
<p>The precise length and position of a <italic>rut</italic> is difficult to predict, since Rho binds RNA with relatively low specificity; however, Rho is believed to favor pyrimidine-rich, unstructured RNA regions (<xref ref-type="bibr" rid="c18">Chhakchhuak et al., 2018</xref>; <xref ref-type="bibr" rid="c55">Nadiras et al., 2018</xref>). The most pyrimidine-rich region of the <italic>topAI</italic> UR is at the very 5’ end. Mutating just four C residues in the Rho-terminated construct of <italic>topAI</italic> (<xref rid="fig1" ref-type="fig">Figure 1B</xref>) caused a 4-fold increase in expression in wild-type cells, but no change in expression in <italic>rho</italic> mutant cells (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). We conclude that the <italic>rut</italic> includes the pyrimidine-rich sequence at the very 5’ end of the <italic>topAI</italic> transcript.</p>
<p>To determine the position of the Rho termination site, we measured transcriptional activity of a “short” <italic>topAI</italic>::<italic>lacZ</italic> fusion that includes only the first 10 bp of the <italic>topAI</italic> ORF (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). The effect of mutating <italic>rho</italic> on expression of this short reporter fusion was substantially lower than that observed for the longer reporter fusion, with no difference in expression observed for the short reporter fusion containing the mutant <italic>rut</italic> sequence (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). This suggests that most of the transcription termination occurs between nucleotides 10 and 42 of the <italic>topAI</italic> coding region. We conclude that Rho loads onto the RNA early in the <italic>topAI</italic> transcript, but does not trigger termination until RNAP is within the ORF, &gt;180 nt further downstream.</p>
<p>Translating ribosomes protect nascent mRNA in protein-coding regions from Rho (<xref ref-type="bibr" rid="c22">de Smit et al., 2009</xref>). Given that Rho termination occurs within the <italic>topAI</italic> ORF, we speculated that <italic>topAI</italic> is translationally repressed. To test whether <italic>topAI</italic> is actively translated, we constructed a <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion (<xref rid="fig2" ref-type="fig">Figure 2A</xref>; <xref rid="fig2s1" ref-type="fig">Figure 2 – figure supplement 1A</xref>). We compared expression of this reporter fusion in wild-type and <italic>rho</italic> mutant cells. Although transcriptional repression of <italic>topAI</italic> is relieved in the <italic>rho</italic> mutant background (<xref rid="fig1" ref-type="fig">Figure 1</xref>), we observed strong repression of the <italic>topAI</italic>-<italic>lux</italic> translation in both wild-type and <italic>rho</italic> mutant cells (<xref rid="fig2s1" ref-type="fig">Figure 2 – figure supplement 1B</xref>). These data suggest that Rho termination within the <italic>topAI</italic> coding region is a consequence of translational repression.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title><italic>topAI</italic> expression is induced in response to translation stress.</title>
<p><bold>(A)</bold> Schematic representation of <italic>topAI</italic>-<italic>lux</italic> translational reporter fusions, indicating the position of the <italic>toiL</italic> start codon with respect to the <italic>topAI</italic> start codon. <bold>(B)</bold> Luciferase activity of the wild-type <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion (pGB202) in Δ<italic>topAI</italic>-<italic>yjhQ</italic> cells (strain GB001) expressing either wild-type 23S rRNA (plasmid pGB322) or ΔT1917 23S rRNA (plasmid pGB318) in <italic>trans</italic>. Activity was measured four hours post-induction with propionate. <bold>(C)</bold> Luciferase activity of wild-type and mutant <italic>topAI</italic>-<italic>lux</italic> translational reporter fusions in Δ<italic>topAI</italic>-<italic>yjhQ</italic> cells (strain GB001) grown in the presence of ribosome-targeting antibiotics. Cells were grown in LB medium to an OD<sub>600</sub> of ∼1.0. Indicated samples were treated with tetracycline (0.5 μg/ml), spectinomycin (90 μg/ml), retapamulin (4 μg/ml), erythromycin (100 μg/ml), tylosin (400 μg/ml), or chloramphenicol (1 μg/ml). Luminescence was measured 90 min after antibiotic treatment. Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2b">
<title><italic>topAI</italic> repression is relieved under conditions of translation stress</title>
<p>Translation repression often occurs by binding of a <italic>trans</italic>-acting factor (e.g., protein, sRNA, small molecule) overlapping the ribosome-binding site (<xref ref-type="bibr" rid="c13">Breaker, 2018</xref>; <xref ref-type="bibr" rid="c39">Kriner et al., 2016</xref>). To identify <italic>trans</italic>-acting regulators of <italic>topAI</italic>, we used a genetic selection for spontaneous mutants with increased <italic>topAI</italic> expression. Briefly, the mutant selection used a <italic>topAI-lacZ</italic> construct in a Δ<italic>lacZ</italic> background; overnight cultures were plated on minimal medium with lactose as the only carbon source, only allowing growth of spontaneous mutants with upregulated <italic>topAI</italic> expression (<italic>cis</italic>-acting mutants were discarded). We isolated 42 mutants with upregulated <italic>topAI</italic> expression. 39 of the mutants had a mutant <italic>rho</italic> gene (see Methods for details), suggesting that the screen was saturating. We isolated three additional mutants that each carry single base mutations in one of the seven copies of the 23S rRNA gene, in domain IV, helix 69 (<italic>rrlA</italic> ΔG1911, <italic>rrlC</italic> ΔT1917) or domain V, helix 80 (<italic>rrlA</italic> G2253T) (Table S1). Mutations in these regions of 23S rRNA have been suggested to cause nonsense and frameshift readthrough, defects in translation fidelity and ribosome assembly, and reduced binding of ribosome release factors (<xref ref-type="bibr" rid="c28">Feinberg and Joseph, 2006</xref>; <xref ref-type="bibr" rid="c30">Gregory et al., 1994</xref>; <xref ref-type="bibr" rid="c32">Hirabayashi et al., 2006</xref>; <xref ref-type="bibr" rid="c36">Kipper et al., 2011</xref>; <xref ref-type="bibr" rid="c45">Liiv et al., 2005</xref>). To test whether the rRNA mutations are sufficient to upregulate <italic>topAI</italic> translation, we expressed wild-type or mutant (23S rRNA ΔT1917) rRNA operons in <italic>trans</italic> in an otherwise wild-type strain, and measured expression of the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion. For these and all additional assays of <italic>topAI</italic>-<italic>lux</italic> reporter fusions, we used a strain lacking <italic>topAI</italic> and <italic>yjhQ</italic>, to rule out the possibility of autoregulation. Supplying the mutant 23S rRNA in <italic>trans</italic> resulted in increased <italic>topAI</italic> expression, whereas wild-type 23S rRNA did not (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). Thus, the 23S rRNA mutation is dominant over the seven chromosomal rRNA operons, suggesting that the effect of the mutations in 23S rRNA genes on <italic>topAI</italic> expression is not simply due to a reduction in levels of active ribosomes.</p>
<p>Expression of toxin-antitoxin genes is often induced by environmental stresses (<xref ref-type="bibr" rid="c61">Page and Peti, 2016</xref>). We next aimed to identify an environmental condition(s) that <italic>topAI</italic> responds to. Given the effect of mutating 23S rRNA on <italic>topAI</italic> expression, we speculated that perturbing translation with ribosome-targeting antibiotics might induce expression of <italic>topAI</italic>. Moreover, increases in <italic>topAI</italic> mRNA levels upon treatment with erythromycin or clindamycin have been reported previously (<xref ref-type="bibr" rid="c27">Dzyubak and Yap, 2016</xref>). We measured expression of the <italic>topAI</italic> translational reporter fusion in cells grown with each of 12 ribosome-targeting antibiotics at sub-inhibitory concentrations. Tetracycline, spectinomycin, retapamulin, tylosin and erythromycin caused increases in expression from 250-fold to 4,000-fold of the <italic>topAI</italic>-<italic>lux</italic> translational fusion (<xref rid="fig2" ref-type="fig">Figure 2C</xref>; Table S2). We observed no change in expression in response to treatment with chloramphenicol (<xref rid="fig2" ref-type="fig">Figure 2C</xref>), kasugamycin, gentamicin, amikacin, streptomycin, apramycin, or hygromycin (Table S2), although we cannot rule out that these antibiotics might induce <italic>topAI</italic> expression at concentrations other than those tested here. Indeed, a previous study showed that <italic>topAI</italic> RNA levels are strongly increased upon treatment with gentamicin (<xref ref-type="bibr" rid="c37">Kohanski et al., 2008</xref>). Another study showed that <italic>topAI</italic> levels are strongly induced upon treatment with kanamycin (<xref ref-type="bibr" rid="c73">Shaw et al., 2003</xref>), an antibiotic not tested in our work. In summary, <italic>topAI</italic> expression is modulated by a wide variety of mechanistically distinct ribosome-targeting antibiotics, reinforcing the idea that expression of this toxin-antitoxin system responds to the translation status of the cell.</p>
<p>To determine whether the relief of translation repression by ribosome-targeting antibiotics also prevents premature Rho-dependent transcription termination, we used ChIP-qPCR to measure the association of RNAP (β subunit) across the <italic>topAI</italic>-<italic>yjhQP</italic> operon in wild-type or <italic>rho</italic> mutant cells grown in the presence or absence of a sub-inhibitory concentration of tetracycline. As a control, we measured the association of RNAP within <italic>rho</italic>, where premature Rho-dependent transcription termination has been previously described (<xref ref-type="bibr" rid="c8">Bastet et al., 2017</xref>; <xref ref-type="bibr" rid="c51">Matsumoto et al., 1986</xref>). For analysis of RNAP association within <italic>rho</italic>, we normalized RNAP occupancy values to those in the <italic>rhoL</italic> region upstream; for <italic>topAI</italic>-<italic>yjhQP</italic>, we normalized RNAP occupancy values within the transcribed regions to those in the promoter region (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). Mutation of <italic>rho</italic> led to a significant, 12.0-fold increase in RNAP occupancy within <italic>rho</italic> (t-test <italic>p</italic> = 0.001), consistent with Rho-dependent transcription termination early in the <italic>rho</italic> transcript (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). Tetracycline treatment in wild-type cells did not lead to a significant increase in RNAP occupancy within <italic>rho</italic> (t-test <italic>p</italic> = 0.1). The combination of mutating <italic>rho</italic> and treating with tetracycline led to a significant, 5.9-fold increase in RNAP occupancy within <italic>rho</italic> (t-test <italic>p</italic> = 0.0009).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Tetracycline treatment reduces premature Rho-dependent transcription termination within <italic>topAI</italic>-<italic>yjhQ</italic> and increases abundance of the associated mRNA.</title>
<p><bold>(A)</bold> Schematic of the <italic>rhoL</italic>-<italic>rho</italic> and <italic>topAI</italic>-<italic>yjhQP</italic> operons showing the positions of PCR amplicons used for ChIP-qPCR and/or qRT-PCR. <bold>(B)</bold> Occupancy of RNAP measured by ChIP-qPCR in the <italic>rho</italic> gene. Occupancy values are normalized to those in <italic>rhoL</italic> (control PCR amplicon “C” in panel A). Data are shown for wild-type (strain MG1655) or <italic>rho</italic> mutant (R66S amino acid substitution in Rho; strain CRB016) cells grown in the presence or absence of tetracycline, as indicated. The <italic>x</italic>-axis label corresponds to the PCR amplicon shown in panel A. <bold>(C)</bold> Occupancy of RNAP measured by ChIP-qPCR at positions across the <italic>topAI</italic>-<italic>yjhQ</italic> transcript. Occupancy values are normalized to those in the <italic>topAI</italic> upstream region (control PCR amplicon “C” in panel A). <bold>(D)</bold> RNA levels measured by qRT-PCR at positions across the <italic>topAI</italic>-<italic>yjhQ</italic> transcript, normalized to the <italic>mreB</italic> gene. Error bars represent ±1 standard deviation from the mean (n = 3). Statistical significance is indicated as follows: n.s. = not significant (<italic>p</italic> &gt; 0.05), * <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, *** <italic>p</italic> &lt; 0.001.</p></caption>
<graphic xlink:href="682021v4_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Mutation of <italic>rho</italic> led to significant, 3.6-, 18.9-, and 17.8-fold increases in RNAP occupancy at three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (<xref rid="fig3" ref-type="fig">Figure 3C</xref>; t-test <italic>p</italic> = 0.009, 0.004, 0.001, respectively). These data are consistent with Rho-dependent transcription termination within <italic>topAI</italic>. The larger increases in RNAP occupancy at later positions within the transcribed region are likely due to a combination of the limited spatial resolution of ChIP-qPCR, and the potential for multiple termination sites within the transcribed region. Tetracycline treatment in wild-type cells led to significant, 1.7-, 7.3-, and 6.7-fold increases in RNAP occupancy at the three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (t-test <italic>p</italic> = 0.03, 0.0009, 0.001, respectively), consistent with tetracycline treatment inhibiting Rho-dependent transcription termination within <italic>topAI</italic>. The combination of mutating <italic>rho</italic> and treating with tetracycline led to 2.0-, 5.7-, and 9.9-fold increases in RNAP occupancy at the three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (t-test <italic>p</italic> = 0.0004, 0.006, 0.005, respectively).</p>
<p>To determine whether the relief of translation repression by ribosome-targeting antibiotics affects the <italic>topAI</italic>-<italic>yjhQP</italic> RNA level, we used qRT-PCR to measure RNA levels at positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon in wild-type or <italic>rho</italic> mutant cells grown in the presence or absence of a sub-inhibitory concentration of tetracycline. Mutation of <italic>rho</italic> led to significant, 7.5-, 5-, and 8.4-fold increases in RNA levels at three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (<xref rid="fig3" ref-type="fig">Figure 3D</xref>; t-test <italic>p</italic> = 0.002, 0.002, 3.5e<sup>−7</sup>, respectively). These data are consistent with Rho-dependent transcription termination within <italic>topAI</italic>. Given that the most upstream region tested is upstream of the likely Rho termination site, these data suggest that premature Rho-dependent transcription termination destabilizes the <italic>topAI</italic>-<italic>yjhQP</italic> mRNA. Tetracycline treatment in wild-type cells led to significant, 4.9-, 2.0-, and 8.0-fold increases in RNA levels at the three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (t-test <italic>p</italic> = 0.008, 0.0007, 8.2e<sup>−6</sup>, respectively), consistent with tetracycline treatment inhibiting Rho-dependent transcription termination within <italic>topAI</italic>. The combination of mutating <italic>rho</italic> and treating with tetracycline led to 18.8-, 5.5-, and 19.9-fold increases in RNA levels at the three positions across the <italic>topAI</italic>-<italic>yjhQP</italic> operon (t-test <italic>p</italic> = 0.01, 0.006, 0.005, respectively). Together, our data support a model in which tetracycline treatment induces translation of <italic>topAI</italic>, which in turn prevents premature Rho-dependent transcription termination within <italic>topAI</italic>.</p>
</sec>
<sec id="s2c">
<title>Expression of a uORF, <italic>toiL</italic>, is required for antibiotic-mediated <italic>topAI</italic> regulation</title>
<p>Long 5′ URs often contain regulatory elements such as uORFs that contribute to regulation of the downstream genes (<xref ref-type="bibr" rid="c39">Kriner et al., 2016</xref>). Given that <italic>topAI</italic> regulation responds to translation perturbation, we searched for a potential uORF that could act as a regulatory module in the <italic>topAI</italic> UR. Through manual inspection of available ribosome profiling data, we identified an 8-codon putative uORF that starts 139 nt upstream of <italic>topAI</italic> (<xref rid="fig4" ref-type="fig">Figure 4A</xref>) (<xref ref-type="bibr" rid="c54">Meydan et al., 2019</xref>; <xref ref-type="bibr" rid="c89">Wang et al., 2015</xref>; <xref ref-type="bibr" rid="c93">Weaver et al., 2019</xref>). A small protein (<italic>Mia</italic>-127) with near-identical amino acid sequence and relative genome position was described in <italic>Salmonella enterica</italic> (<xref rid="fig4s1" ref-type="fig">Figure 4, figure supplement 1</xref>) (<xref ref-type="bibr" rid="c5">Baek et al., 2017</xref>). To experimentally determine the frame and position of this uORF, which we renamed <italic>toiL</italic> (<underline>to</underline>poisomerase inhibitor leader) in <italic>E. coli</italic> K-12, we measured expression of a <italic>toiL-lacZ</italic> translational fusion. Replacing native codons with stop codons in the predicted CDS prevented expression of this fusion, unlike the equivalent substitution upstream of the ORF (<xref rid="fig4" ref-type="fig">Figure 4</xref>), supporting our ORF prediction. The first 7 amino acids of the ToiL protein are conserved across bacteria that encode the <italic>topAI-yjhQP</italic> operon (<xref rid="fig4s1" ref-type="fig">Figure 4 – figure supplement 1</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>A uORF, <italic>toiL</italic>, is located within the <italic>topAI</italic> 5’ upstream region.</title>
<p><bold>(A)</bold> Schematic representation of <italic>toiL</italic>-<italic>lacZ</italic> translational reporter fusions, indicating mutations upstream and within the <italic>toiL</italic> uORF. <bold>(B)</bold> β-galactosidase activity of the wild-type <italic>toiL</italic>-<italic>lacZ</italic> translational reporter fusion (wt; plasmid pGB164), and fusions with mutations immediately upstream of <italic>toiL</italic> (TTG→tga; plasmid pGB201), at the <italic>toiL</italic> start codon (ATG→tga; plasmid pGB200), second codon (CTG→tga; plasmid pGB197), or fourth codon (AAT→tga; plasmid pGB196), in cells with wild-type <italic>topAI</italic>-<italic>yjhQP</italic> (strain AMD054). Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>To determine if <italic>toiL</italic> is a regulatory uORF, we tested whether expression of the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion is induced by ribosome-targeting antibiotics if <italic>toiL</italic> translation is impaired. We first mutated the start codon of <italic>toiL</italic> from ‘ATG’ to ‘gTa’ (<xref rid="fig5" ref-type="fig">Figure 5A</xref>; the specific substitutions were made to preserve the predicted secondary structure of the 5′ UR; <xref rid="fig5s1" ref-type="fig">Figure 5 – figure supplement 1A</xref>). The start codon mutation (<xref rid="fig5" ref-type="fig">Figure 5A</xref>; <xref rid="fig5s1" ref-type="fig">Figure 5 – figure supplement 1B</xref>) did not impact expression of a <italic>topAI</italic>-<italic>lux</italic> transcriptional reporter fusion that used the entire UR for <italic>topAI</italic> (<xref rid="fig5s1" ref-type="fig">Figure 5 – figure supplement 1C</xref>), indicating that the mutation does not cause premature Rho termination. We measured expression of the wild-type and mutant <italic>topAI</italic>-<italic>lux</italic> translational fusions in the presence or absence of sub-inhibitory concentrations of ribosome-targeting antibiotics. The <italic>toiL</italic> start codon mutation caused a 12- to 110-fold decrease in <italic>topAI</italic> induction by antibiotics (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). Nonetheless, antibiotics were still able to modestly induce <italic>topAI</italic> expression. The <italic>toiL</italic> start codon is flanked by in-frame TTG and CTG trinucleotides that could potentially function as secondary start codons, perhaps explaining why mutation of the ATG start codon did not completely abolish the effect of antibiotic treatment. To test this possibility, we disrupted the predicted <italic>toiL</italic> Shine-Dalgarno (S-D) sequence (<xref rid="fig5" ref-type="fig">Figure 5A</xref>) and measured <italic>topAI</italic>-<italic>lux</italic> induction by ribosome-targeting antibiotics. Disruption of the <italic>toiL</italic> S-D site abolished induction of <italic>topAI</italic> expression by all antibiotics tested (<xref rid="fig5" ref-type="fig">Figure 5B</xref>), supporting the idea that active translation of <italic>toiL</italic> is absolutely required for <italic>topAI</italic> regulation by ribosome-targeting antibiotics.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title><italic>toiL</italic> translation is required for induction of <italic>topAI</italic> expression by ribosome-targeting antibiotics.</title>
<p><bold>(A)</bold> Schematic representation of <italic>topAI</italic>-<italic>lux</italic> translational reporter fusions, indicating mutations in the start codon and Shine-Dalgarno sequence of the <italic>toiL</italic> uORF. <bold>(B)</bold> Luciferase activity of wild-type and mutant <italic>topAI</italic>-<italic>lux</italic> translational reporter fusions in Δ<italic>topAI</italic>-<italic>yjhQ</italic> cells (strain GB001) grown in the presence of ribosome-targeting antibiotics. Cells were grown as indicated in <xref rid="fig2" ref-type="fig">Figure 2C</xref>. Dark gray bars show data for the wild-type <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion (plasmid pGB202); light gray bars show data for the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion with a mutated <italic>toiL</italic> start codon (plasmid pGB313); white bars show data for the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion with a mutated <italic>toiL</italic> Shine-Dalgarno sequence (pGB366). Note that data for the wild-type <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion are identical to those in <xref rid="fig2" ref-type="fig">Figure 2C</xref> and are included here for reference. Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2d">
<title>Tetracycline causes de-repression of <italic>topAI</italic> translation by disrupting base-pairing around the <italic>topAI</italic> ribosome-binding site</title>
<p>Long URs that encode uORFs often utilize alternating RNA structures to modulate expression of the downstream gene (<xref ref-type="bibr" rid="c39">Kriner et al., 2016</xref>). For <italic>topAI</italic>, the class of regulatory element (i.e., a uORF) and the type of inducer (i.e., ribosome-targeting antibiotics) closely resembles the regulation of rRNA methyltransferase genes <italic>ermB</italic>/<italic>ermC</italic> (<xref ref-type="bibr" rid="c80">Subramanian et al., 2012</xref>), where stalling of the ribosome within a uORF in the presence of certain macrolide antibiotics alters the downstream RNA structure, facilitating <italic>ermB</italic>/<italic>ermC</italic> translation. Computational prediction of the <italic>topAI</italic> UR RNA secondary structure suggests that sequences within <italic>toiL</italic> base-pair with the <italic>topAI</italic> ribosome-binding site (<xref rid="fig6" ref-type="fig">Figure 6A</xref>). Consistent with this prediction, the 5’ UR of <italic>toiL</italic> has been reported to form an extended region of dsRNA (<xref ref-type="bibr" rid="c47">Lybecker et al., 2014</xref>). Base-pairing between <italic>toiL</italic> and the <italic>topAI</italic> ribosome-binding site is further supported by a structural prediction that incorporates sequence conservation information from orthologous regions in related species (<xref rid="fig6s1" ref-type="fig">Figure 6 – figure supplement 1</xref>).</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Structural changes in the <italic>topAI</italic> 5′ upstream region induced by tetracycline treatment.</title>
<p><bold>(A)</bold> Predicted RNA secondary structure of the <italic>topAI</italic> 5’ UR, indicating in-cell SHAPE reactivities of each base from an untreated sample. Values of ρ are indicated on a color gradient. The position of the <italic>toiL</italic> uORF is indicated by a red arrow, and the position of the start of <italic>topAI</italic> is indicated by a gray rectangle. Numbers indicate position relative to the mRNA 5’ end. <bold>(B)</bold> In-cell SHAPE reactivities of each base from three replicates of untreated samples and two replicates of tetracycline-treated samples. SHAPE reacrtivity values are indicated on the same color gradient as panel A. Nucleotide positions with statistically significant differences (<italic>p</italic> &lt; 0.01 or 0.05, as indicated) in SHAPE reactivity between untreated and tetracycline-treated samples are indicated by red (lower reactivity in tetracycline-treated samples) or green (higher reactivity in tetracycline-treated samples) squares.</p></caption>
<graphic xlink:href="682021v4_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>We used in-cell SHAPE-seq (<xref ref-type="bibr" rid="c91">Watters et al., 2016a</xref>) to experimentally assess the <italic>topAI</italic> UR RNA secondary structure, and to investigate changes in secondary structure that occur upon tetracycline treatment. The SHAPE reagent, 1M7, penetrates live cells and modifies the backbone of accessible RNA nucleotides. In the subsequent RNA library preparation steps, modified nucleotides block reverse transcription (RT), creating RT-stop points that are detected bioinformatically after the 1M7-treated and untreated libraries are sequenced. Lower SHAPE reactivity is an indication of increased base-pairing interactions or nucleotide occlusion by other cellular factors such as ribosome binding. The SHAPE-seq data for untreated cells were in good agreement with the computationally predicted structure of the <italic>topAI</italic> UR (<xref rid="fig6" ref-type="fig">Figure 6A</xref>; Table S3): the beginning of the 5’ mRNA end is highly reactive, as are predicted loops. We speculate that moderate reactivity in the <italic>toiL</italic> coding region is the result of translating ribosomes that temporarily disrupt the predicted long-range base-pairing interactions. Tetracycline treatment significantly altered reactivity (<italic>p</italic> &lt; 0.05; see Methods for details) in two distinct regions in the 5′ region in comparison to the untreated control: sequence from the <italic>toiL</italic> S-D to the <italic>toiL</italic> start codon became less reactive, whereas the <italic>topAI</italic> S-D became more reactive (<xref rid="fig6" ref-type="fig">Figure 6B</xref>; Table S3). We propose that, in the presence of tetracycline, initiating ribosomes stall at the start of <italic>toiL</italic>, which leads to a decrease in base-pairing between <italic>toiL</italic> and the <italic>topAI</italic> S-D. No significant changes in the <italic>toiL</italic> ORF region were observed as a result of tetracycline treatment (<italic>p</italic> &gt; 0.05), likely due to these nucleotides switching from occlusion by base-pairing to occlusion by a stalled ribosome. The increase in reactivity around the <italic>topAI</italic> S-D following tetracycline treatment is statistically significant, but modest, suggesting that loss of base-pairing between <italic>toiL</italic> and this region is transient, and/or that a ribosome initiating translation of <italic>topAI</italic> partially prevents access to the SHAPE reagent.</p>
</sec>
<sec id="s2e">
<title>Tetracycline stalls ribosomes at the start codon of <italic>toiL</italic> and at start codons across the transcriptome</title>
<p>To directly measure ribosome positioning within <italic>toiL in vivo</italic>, we used ribosome profiling to map ribosome occupancy across the <italic>E. coli</italic> transcriptome in untreated cells, and cells treated with tetracycline. A comparison of ribosome occupancy across all genes showed that <italic>topAI</italic> and its operonic genes <italic>yjhQ</italic> and <italic>yjhP</italic> are among the most strongly induced by tetracycline (<xref rid="fig7" ref-type="fig">Figure 7A</xref>; Table S4; note that induction could be at the level of RNA abundance, translation, or both). For cells treated with tetracycline, ribosome occupancy throughout <italic>toiL</italic> was substantially higher than in untreated cells. When mapping the 3’ ends of ribosome-protected RNA fragments, we observed a strong peak at position +18 of <italic>toiL</italic>, a location consistent with the downstream edge of a ribosome stalled at the <italic>toiL</italic> start codon (<xref rid="fig7" ref-type="fig">Figure 7B</xref>). To determine whether tetracycline induces ribosome stalling in other ORFs, we compared ribosome occupancy in the region around the start codons of all annotated ORFs. Tetracycline induced stalling at positions +16 to +18 relative to start codons (<xref rid="fig7" ref-type="fig">Figure 7C</xref>), consistent with ribosomes stalled at start codons, as has been described for tetracycline in an earlier study (<xref ref-type="bibr" rid="c56">Nakahigashi et al., 2016</xref>). We conclude that tetracycline induces expression of <italic>topAI</italic> by stalling ribosomes at the start codon of <italic>toiL</italic>. We reasoned that retapamulin, a ribosome-targeting antibiotic that traps initiating ribosomes on start codons (<xref ref-type="bibr" rid="c54">Meydan et al., 2019</xref>; <xref ref-type="bibr" rid="c97">Yan et al., 2006</xref>) would induce <italic>topAI</italic> expression by the same mechanism. Consistent with this prediction, retapamulin strongly induced (∼600-fold) expression of the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion (<xref rid="fig2" ref-type="fig">Figure 2C</xref>), and induction by retapamulin depended upon active translation of <italic>toiL</italic> (<xref rid="fig5" ref-type="fig">Figure 5B</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Tetracycline stalls ribosomes on start codons.</title>
<p><bold>(A)</bold> Normalized Ribo-seq coverage for all annotated ORFs for cells (strain MG1655) grown ± tetracycline. <bold>(B)</bold> Heatmap showing normalized Ribo-seq coverage in the region around the <italic>toiL</italic> uORF in untreated cells (no antibiotic) or tetracycline-treated cells. The color indicates the sequence-read coverage for RNA fragment 3’ ends that are presumed to represent the downstream edge of ribosome footprints. The <italic>toiL</italic> uORF position and encoded amino acid sequence is indicated. <bold>(C)</bold> Average of normalized Ribo-seq coverage for the regions around start codons for all annotated ORFs, for untreated cells (gray line; no antibiotic) or tetracycline-treated cells (orange line). Sequence-read coverage was calculated for RNA fragment 3’ ends that are presumed to represent the downstream edge of ribosome footprints.</p></caption>
<graphic xlink:href="682021v4_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2f">
<title>Mapping ribosome stalling sites induced by different antibiotics</title>
<p>At least five different ribosome-targeting antibiotics induce expression of <italic>topAI</italic>-<italic>yjhQP</italic> (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). We speculated that these antibiotics, like tetracycline, induce <italic>topAI</italic>-<italic>yjhQP</italic> expression by stalling ribosomes within <italic>toiL</italic>, preventing base-pairing between the <italic>toiL</italic> ORF and the <italic>topAI</italic> S-D. Moreover, because these antibiotics have different targets within the ribosome and a range of mechanisms of action, we speculated that stalling might occur at different positions in <italic>toiL</italic> depending on the antibiotic used. To further assess potential ribosome stalling at <italic>toiL in vivo,</italic> we used a modified version of a previously described stalling reporter construct (<xref ref-type="bibr" rid="c6">Bailey et al., 2008</xref>). Macrolide-mediated induction of this reporter relies on ribosome stalling at codon Ile9 of the <italic>ermCL</italic> uORF. We designed a hybrid construct where progressively longer segments of the <italic>toiL</italic> ORF, extending towards the 3’ end, are fused to the <italic>ermCL</italic> 10<sup>th</sup> codon and the remaining downstream sequence, followed by a luciferase reporter gene (<xref rid="fig8" ref-type="fig">Figure 8A-B</xref>; <xref rid="fig8s1" ref-type="fig">Figure 8, figure supplement 1</xref>). These constructs include the RNA structural features from the <italic>ermCL-ermC</italic> intergenic region that are altered in response to ribosome stalling upstream. Thus, ribosome stalling within <italic>toiL</italic> sequences, close to the junction with <italic>ermCL</italic>, is expected to induce expression of the luciferase reporter gene (<xref rid="fig8" ref-type="fig">Figure 8A</xref>; <xref rid="fig8s1" ref-type="fig">Figure 8 – figure supplement 1</xref>). We measured expression of the stalling reporter constructs in a strain lacking <italic>topAI</italic> and <italic>yjhQ</italic>. As a control, we replaced <italic>toiL</italic> with the native <italic>ermCL</italic> sequence to show that this reporter is responsive to erythromycin treatment, but not other antibiotics (<xref rid="fig8s2" ref-type="fig">Figure 8 – figure supplement 2</xref>). Tetracycline and retapamulin induced expression most strongly with the fusion to the start codon of <italic>toiL</italic> (<xref rid="fig8" ref-type="fig">Figure 8C</xref>), consistent with ribosome stalling at the start codon. Tylosin induced expression of only the 5-codon fusion reporter construct, suggesting tylosin-induced stalling at Val5. The effect of tylosin on expression of this reporter was abolished by the Val5→Leu mutation (<xref rid="fig8" ref-type="fig">Figure 8C</xref>). Interestingly, tetracycline, retapamulin and erythromycin also showed some induction with the 5-codon <italic>toiL</italic> fusion, with the effect reduced by the Val5→Leu mutation (<xref rid="fig8" ref-type="fig">Figure 8C</xref>); additional stalling at this codon might have an additive effect on <italic>topAI</italic> induction. Erythromycin induced expression most strongly with the construct that has the complete <italic>toiL</italic> ORF, including the stop codon (<xref rid="fig8" ref-type="fig">Figure 8C</xref>), suggesting that ribosomes stall during translation termination. Spectinomycin induced expression of several constructs, but the level of induction was lower than for other antibiotics (<xref rid="fig8" ref-type="fig">Figure 8C</xref>), despite being able to induce <italic>topAI</italic> to a similar extent to tetracycline (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). Chloramphenicol did not induce expression of any of the constructs, consistent with its inability to induce expression of <italic>topAI</italic> (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). Overall, these data suggest that a variety of ribosome-targeting antibiotics cause ribosomes to stall within <italic>toiL</italic>, with different antibiotics stalling ribosomes at different positions. Moreover, the data suggest that ribosome stalling at a variety of positions within <italic>toiL</italic> is sufficient to induce <italic>topAI</italic>-<italic>yjhQP</italic> expression.</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Ribosome stalling at the <italic>topAI</italic> leader <italic>in vivo</italic>.</title>
<p><bold>(A)</bold> Schematic showing the <italic>toiL</italic>-<italic>ermCL</italic>-<italic>lux</italic> stalling reporter in the translationally inactive conformation (“OFF”) that is expected in the absence of ribosome stalling, and the translationally active conformation (“ON”) that is expected when ribosomes stall within <italic>toiL</italic> sequence close to the junction of <italic>toiL</italic> with <italic>ermCL</italic>. <bold>(B)</bold> Schematic showing <italic>toiL</italic>-<italic>ermCL</italic> stalling reporters where <italic>toiL</italic> is progressively extended by one codon at the 3’ end and fused to part of <italic>ermCL</italic>. <italic>toiL</italic> sequence is indicated by red arrows; <italic>ermCL</italic> sequence is indicated by green arrows. The last indicated stalling reporter extends to position 5 of <italic>toiL</italic> but has a Val5→Leu substitution (blue). <bold>(C)</bold> Luciferase activity of the <italic>toiL</italic>-<italic>ermCL</italic>-<italic>lux</italic> stalling reporters (plasmids pGB323, pGB346, pGB325, pGB326, pGB324, pGB328, pGB329, pGB307, pGB347, and pGB327) in Δ<italic>topAI-yjhQ</italic> cells (strain GB001). Cells were grown to an OD<sub>600</sub> of ∼1.0 and treated with the indicated ribosome-targeting antibiotics at the same concentrations as in <xref rid="fig2" ref-type="fig">Figure 2C</xref>. Luminescence was measured three hours post-treatment. Horizontal dashed lines indicate luminescence activity of 1, to facilitate comparison between panels with different <italic>y</italic>-axis scales. Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<sec id="s3a">
<title>Model for <italic>topAI</italic> regulation</title>
<p>We propose the following model for <italic>topAI</italic> regulation (<xref rid="fig9" ref-type="fig">Figure 9</xref>): In the absence of translation stress, a hairpin that encompasses the <italic>toiL</italic> uORF and the <italic>topAI</italic> ribosome-binding side prevents initiation of <italic>topAI</italic> translation, which in turn promotes premature Rho-dependent transcription termination within the <italic>topAI</italic> ORF. Under these repressive conditions, <italic>toiL</italic> is presumably being efficiently translated, but ribosomes translating <italic>toiL</italic> only transiently disrupt the hairpin. Upon induction of certain types of translation stress, notably ribosome inhibition by select antibiotics, ribosomes stall within <italic>toiL</italic>, disrupting the repressive hairpin and leading to translation of <italic>topAI</italic>, which in turn prevents Rho-dependent transcription termination within <italic>topAI</italic>. <italic>topAI</italic>-<italic>yjhQP</italic> RNA levels in the <italic>rho</italic> R66S mutant increase ∼2-fold upon tetracycline treatment (<xref rid="fig3" ref-type="fig">Figure 3D</xref>), suggesting an additional, albeit modest level of regulation at the level of mRNA stability. This could be due to a stabilizing effect of translation (<xref ref-type="bibr" rid="c24">Deana and Belasco, 2005</xref>), or direct regulation of RNase accessibility in the 5’ UR.</p>
<fig id="fig9" position="float" orientation="portrait" fig-type="figure">
<label>Figure 9.</label>
<caption><title>Model for regulation of <italic>topAI</italic> expression.</title>
<p>Schematic showing a model for regulation of <italic>topAI</italic> expression. In the repressed state, a hairpin forms between the <italic>toiL</italic> sequence and the ribosome-binding site of <italic>topAI</italic>, repressing translation, which in turn promotes premature Rho-dependent transcription termination within the <italic>topAI</italic> gene. When cells are treated with certain ribosome-targeting antibiotics such as tetracycline, ribosomes stall within <italic>toiL</italic> in a sequence-specific manner, preventing formation of the repressive hairpin.</p></caption>
<graphic xlink:href="682021v4_fig9.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3b">
<title><italic>toiL</italic> is a multipurpose sensory uORF</title>
<p>Sensory uORFs are versatile regulators that have evolved to rapidly alter physiology in response to a wide variety of environmental stresses that impact translation. However, most regulatory uORFs characterized to date have been proposed to respond to a single translational stress. By contrast, <italic>toiL</italic> senses a wide variety of ribosome-targeting antibiotics with unrelated mechanisms of action. The ability of <italic>toiL</italic> to transduce a wide range of translational stress signals is likely due to the fact that base-pairing with the <italic>topAI</italic> ribosome-binding site occurs across the length of the <italic>toiL</italic> ORF; hence, ribosome stalling anywhere within <italic>toiL</italic> would likely prevent hairpin formation, relieving <italic>topAI</italic> repression. This likely explains why mutations in helix 69 and helix 80 of the 23S rRNA induce expression of <italic>topAI</italic>, since residues in these helices have been reported to promote ribosome processivity (<xref ref-type="bibr" rid="c35">Kipper et al., 2009</xref>; <xref ref-type="bibr" rid="c67">Samaha et al., 1995</xref>), and the impact of ribosomes slowing as they translate <italic>toiL</italic> could be similar to that of a ribosome stall. Many antibiotics have been shown to stall ribosomes in ORFs in a sequence-specific manner (<xref ref-type="bibr" rid="c59">Orelle et al., 2013</xref>; <xref ref-type="bibr" rid="c85">Vázquez-Laslop and Mankin, 2018a</xref>). We speculate that the <italic>toiL</italic> sequence has evolved to stall ribosomes in a sequence-specific manner in response to a variety of antibiotics.</p>
<p>There are a few other examples of uORFs where more than one class of antibiotic can induce ribosome stalling. <italic>Clostridiodes difficile cplR</italic> is regulated by a uORF that senses retapamulin and lincomycin (<xref ref-type="bibr" rid="c58">Obana et al., 2023</xref>). <italic>Bacillus subtilis vmlR</italic> is regulated by a uORF that senses retapamulin, lincomycin, iboxamycin (<xref ref-type="bibr" rid="c82">Takada et al., 2022</xref>). And <italic>Staphylococcus haemolyticus vga(A)</italic> is regulated by a uORF that senses lincosamides, streptogramin A, and pleuromutilins (<xref ref-type="bibr" rid="c88">Vimberg et al., 2020</xref>). However, in these cases, the antibiotics all likely function to stall ribosomes at start codons (<xref ref-type="bibr" rid="c82">Takada et al., 2022</xref>). Hence, even though the antibiotics have different targets within the ribosome, the position of ribosome stalling is the likely to be the same. By contrast, our data strongly suggest that while tetracycline and retapamulin stall ribosomes at the <italic>toiL</italic> start codon, tylosin, spectinomycin and erythromycin stall ribosomes further downstream.</p>
<p>Another uORF that is known to sense multiple classes of ribosome-targeting antibiotics is found upstream of the actinobacterial gene <italic>whiB7</italic> (<xref ref-type="bibr" rid="c14">Burian and Thompson, 2018</xref>; <xref ref-type="bibr" rid="c42">Lee et al., 2022</xref>). Whether antibiotics induce ribosome stalling within the <italic>whiB7</italic>-associated uORF has not been tested. Intriguingly, <italic>whiB7</italic> expression can also be induced by amino acid starvation (<xref ref-type="bibr" rid="c42">Lee et al., 2022</xref>), suggesting that non-antibiotic stresses that lead to ribosome stalling within the uORF can also contribute to regulation. An artificial uORF-regulated reporter construct has also been generated that responds to a variety of ribosome-targeting antibiotics, albeit to lesser extent than <italic>topAI</italic> or <italic>whiB7</italic>; the mechanism of uORF regulation in response to antibiotic treatment was presumed to involve ribosome stalling in the uORF, although this has not been tested (<xref ref-type="bibr" rid="c60">Osterman et al., 2012</xref>).</p>
</sec>
<sec id="s3c">
<title>Understanding how different antibiotics stall ribosomes within <italic>toiL</italic></title>
<p>The mechanism by which tetracycline stalls ribosomes at start codons has not been determined. Tetracycline binds to the 30S ribosomal subunit in the decoding center, and likely functions by preventing association of aminoacyl-tRNAs with the A-site (<xref ref-type="bibr" rid="c57">Nguyen et al., 2014</xref>). We speculate that tetracycline binds to initiating ribosomes when the A-site is free, preventing association of an aminoacyl-tRNA in the A-site, an essential step prior to formation of the first peptide bond in the nascent peptide. Intriguingly, regulation of tetracycline resistance can involve a uORF (<xref ref-type="bibr" rid="c19">Chopra and Roberts, 2001</xref>), including one case where the uORF is only four codons long (<xref ref-type="bibr" rid="c90">Wang et al., 2005</xref>), consistent with regulation by ribosome stalling at the start codon.</p>
<p>Macrolides such as erythromycin function by binding in the nascent peptide exit tunnel of the ribosome (<xref ref-type="bibr" rid="c86">Vázquez-Laslop and Mankin, 2018b</xref>). Ribosome stalling induced by erythromycin is well-established for uORFs upstream of macrolide-resistance genes (<xref ref-type="bibr" rid="c64">Ramu et al., 2009</xref>), where the nascent peptide in the exit tunnel senses the presence of erythromycin, leading to structural changes that prevent peptide bond formation. Our data are consistent with erythromycin inducing ribosome stalling at the end of <italic>toiL</italic> (<xref rid="fig8" ref-type="fig">Figure 8C</xref>), suggesting that the nascent peptide senses erythromycin, leading to structural changes that inhibit the action of release factors. Indeed, erythromycin was recently shown to stall ribosomes at the penultimate codon of the <italic>Streptococcus msrDL</italic> uORF by altering the 23S rRNA structure to prevent release factor binding (<xref ref-type="bibr" rid="c29">Fostier et al., 2023</xref>). When ribosomes stall on <italic>msrDL</italic> in the presence of erythromycin, the N<sub>-3</sub> and N<sub>-2</sub> amino acids with respect to the C-terminal residue are leucine and isoleucine respectively, and the stop codon is UAA. The N<sub>-3</sub> and N<sub>-2</sub> amino acids are the closest to erythromycin in the peptide exit tunnel (<xref ref-type="bibr" rid="c29">Fostier et al., 2023</xref>). Assuming erythromycin induces stalling of ribosomes on the penultimate codon of <italic>toiL</italic>, the N<sub>-3</sub> and N<sub>-2</sub> amino acids amino acids would be valine and isoleucine, respectively, and the stop codon is UAA, suggesting a similar interaction of the ToiL and MsrDL nascent peptides with erythromycin, and a similar mechanism of stalling.</p>
<p>Tylosin is also a macrolide, and stalling induced by tylosin has also been observed previously at an RYR sequence in <italic>Bacillus subtilis</italic> (<xref ref-type="bibr" rid="c95">Yakhnin et al., 2019</xref>). This suggests a similar mechanism of action to erythromycin, which can stall ribosomes at R/K-X-R/K motifs (<xref ref-type="bibr" rid="c21">Davis et al., 2014</xref>; <xref ref-type="bibr" rid="c64">Ramu et al., 2009</xref>). By contrast, our data suggest that tylosin induces ribosome stalling at Val5 of <italic>toiL</italic> (<xref rid="fig8" ref-type="fig">Figure 8C</xref>). Despite the apparent preference for R/K-X-R/K motifs for tylosin-induced ribosome stalling, tylosin has been observed to stall ribosomes at other sequences (<xref ref-type="bibr" rid="c59">Orelle et al., 2013</xref>), suggesting that the sequence requirements for tylosin-induced stalling are complex, as they are for erythromycin (<xref ref-type="bibr" rid="c64">Ramu et al., 2009</xref>).</p>
<p>Spectinomycin also induces expression of <italic>topAI</italic> in a <italic>toiL</italic>-dependent manner, although our data suggest that spectinomycin does not lead to ribosome stalling at a single codon position in <italic>toiL</italic> (<xref rid="fig8" ref-type="fig">Figure 8C</xref>). Little is known about the effects of spectinomycin on ribosome stalling, but it has been shown to stall ribosomes at specific sequences within ORFs (<xref ref-type="bibr" rid="c59">Orelle et al., 2013</xref>).</p>
</sec>
<sec id="s3d">
<title>The link between translation attenuation and premature Rho-dependent termination</title>
<p>In addition to directly regulating translation of <italic>topAI</italic>, <italic>toiL</italic> indirectly regulates <italic>topAI</italic> transcription by modulating Rho-dependent transcription termination within the <italic>topAI</italic> ORF. We speculate that Rho prematurely terminates transcription of other uORF-regulated genes where the uORF modulates translation, similar to the function of some riboswitches (<xref ref-type="bibr" rid="c9">Bastet et al., 2018</xref>). Other studies of premature Rho termination events within coding regions suggested that termination occurs due to the unmasking of Ruts within the ORF that are otherwise occluded by translating ribosomes (<xref ref-type="bibr" rid="c8">Bastet et al., 2017</xref>; <xref ref-type="bibr" rid="c10">Ben-Zvi et al., 2019</xref>; <xref ref-type="bibr" rid="c12">Bossi et al., 2012</xref>; <xref ref-type="bibr" rid="c23">de Smit et al., 2008</xref>). By contrast, the Rut for <italic>topAI</italic> is located within the 5′ UR. This suggests that the mechanism by which translation of <italic>topAI</italic> prevents Rho termination is distinct to that of other characterized examples of prematurely Rho-terminated genes. Specifically, ribosomes translating <italic>topAI</italic> likely prevent Rho from catching the elongating RNAP, rather than preventing Rho loading onto the nascent RNA. If there are indeed two distinct mechanisms by which ribosomes can prevent Rho termination, the level of translation required for each mechanism may be different. An alternative possibility is that the <italic>topAI</italic> Rut is very long and extends into the <italic>topAI</italic> ORF, in which case ribosomes could prevent Rho termination by preventing Rho loading.</p>
<p>We identified elements of the <italic>topAI</italic> Rut that are located a short distance upstream of <italic>toiL</italic>. Given the length of RNA required to constitute a Rut, the <italic>topAI</italic> Rut must overlap <italic>toiL</italic>. Thus, the Rut is functional despite the presence of an overlapping ORF that is actively translated. We propose that (i) Rho can only load onto the <italic>topAI</italic> 5′ region after translation of <italic>toiL</italic> is terminated, or (ii) Rho can loop the RNA around the <italic>toiL</italic> region to access upstream and downstream elements of the Rut. It has previously been proposed that Rho can step over an RNA roadblock to access available Ruts (<xref ref-type="bibr" rid="c38">Kriner and Groisman, 2017</xref>; <xref ref-type="bibr" rid="c69">Schwartz et al., 2007</xref>), thereby helping Rho to overcome roadblocks in the 5′ region.</p>
</sec>
<sec id="s3e">
<title>Concluding remarks</title>
<p>uORFs permit rapid regulation in response to translational stress. For almost all previous uORFs shown to sense antibiotics, the downstream gene is functionally related to antibiotic resistance, often directly promoting resistance to the antibiotic(s) that induce expression. Although <italic>topAI</italic> has been characterized as a DNA gyrase inhibitor (<xref ref-type="bibr" rid="c96">Yamaguchi and Inouye, 2015</xref>), we speculate that <italic>topAI</italic> and/or <italic>yjhQ</italic>/<italic>P</italic>, which are transcribed from the same operon, have additional functions that are linked to the small molecule that <italic>toiL</italic> has evolved to sense. This small molecule could be a ribosome-targeting antibiotic, or a non-antibiotic molecule such as an amino acid or polyamine, which promote ribosome stalling in other uORFs (<xref ref-type="bibr" rid="c31">Herrero Del Valle et al., 2020</xref>; <xref ref-type="bibr" rid="c84">van der Stel et al., 2021</xref>).</p>
<p>There has been a recent explosion in the discovery of bacterial sORFs, many of which are located short distances upstream of canonical ORFs on the same strand (<xref ref-type="bibr" rid="c54">Meydan et al., 2019</xref>; <xref ref-type="bibr" rid="c76">Smith et al., 2022</xref>; <xref ref-type="bibr" rid="c77">Stringer et al., 2021</xref>; <xref ref-type="bibr" rid="c87">Venturini et al., 2020</xref>; <xref ref-type="bibr" rid="c93">Weaver et al., 2019</xref>). We speculate that there are large numbers of regulatory uORFs even in a well-characterized bacterium like <italic>E. coli</italic>. Indeed, analysis of ribosome profiling data for cells treated with tetracycline revealed &gt;5-fold increases in ribosome-associated RNA levels relative to untreated cells for several genes that are known to be associated with a uORF (Table S4), including <italic>mgtA</italic>, <italic>corA</italic> and <italic>speC</italic>.</p>
</sec>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title>Strains and plasmids</title>
<p>All strains and plasmids used in this study are listed in Table S5. All oligonucleotides used in this study are listed in Table S6. An <italic>E. coli</italic> MG1655 Δ<italic>lacZ</italic> Δ<italic>topAI</italic>-<italic>yjhQ</italic>::<italic>thyA</italic> strain (GB001) was constructed using the FRUIT recombineering method (<xref ref-type="bibr" rid="c79">Stringer et al., 2012</xref>). Briefly, the <italic>thyA</italic> gene was amplified using primers JW7676 + JW7677 and electroporated into strain AMD189 (MG1655 Δ<italic>lacZ</italic> Δ<italic>thyA</italic>) (<xref ref-type="bibr" rid="c79">Stringer et al., 2012</xref>) to replace the <italic>topAI</italic> gene from 379 bp upstream of <italic>topAI</italic> to 74 bp into the <italic>yjhQ</italic> coding region.</p>
<p>All <italic>topAI</italic> and <italic>toiL lacZ</italic> and luciferase reporter plasmids (pJTW100, pGB164, pGB182, pGB196, pGB197, pGB200, pGB201, pGB202, pGB215, pGB217, pGB297, pGB305, pGB306, pGB313) were made to include sequence starting at −400 bp upstream of <italic>topAI</italic> and were presumed to include the native <italic>topAI</italic> promoter. Fusions to <italic>lacZ</italic> are derivatives plasmid pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>). Fusions to luciferase are derivatives of pGB135, which includes the <italic>luxCDABE</italic> operon from <italic>Photorhabdus luminescens</italic>. Constructing pGB135 first required construction of plasmid pGB96. pGB96 was made by PCR-amplification of a region from plasmid pJTW064 (<xref ref-type="bibr" rid="c78">Stringer et al., 2014</xref>) using primers JW8044 + JW8045, PCR-amplification of a region from pCS-PesaRlux (<xref ref-type="bibr" rid="c74">Shong and Collins, 2013</xref>) using primers JW8046 + JW8047, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pET-PesaRlux cut with <italic>Xho</italic>I and <italic>Xba</italic>I (<xref ref-type="bibr" rid="c74">Shong and Collins, 2013</xref>). pGB135 was made by PCR-amplification of two regions from pGB96 using primers JW8044 + JW8522 and JW8523 + JW8047, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pCS-PesaRlux cut with <italic>Xho</italic>I and <italic>Xba</italic>I (<xref ref-type="bibr" rid="c74">Shong and Collins, 2013</xref>). pGB135 has the P<italic>esaR</italic> fragment from pCS-PesaRlux replaced with a constitutive promoter and convenient restriction sites for transcriptional or translation fusions to the <italic>luxC</italic> gene; transcriptional reporter fusions included a Shine-Dalgarno sequence, whereas translational fusions used the sequence up to the initiation codon of the gene of interest followed by the second codon of the reporter gene.</p>
<p>Plasmid pJTW100 is a derivative of pAMD033 that includes a full-length <italic>topAI</italic> gene and the first 90 bp of <italic>yjhQ</italic> translationally fused to <italic>lacZ</italic>. pJTW100 was constructed by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW5638 + JW5639, and cloning the resultant PCR product into pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>) cut with <italic>Sph</italic>I and <italic>Hin</italic>dIII.</p>
<p>Plasmids pGB215 and pGB217 are derivatives of pAMD033 with sequence up to position +10 or +42 of <italic>topAI</italic> (relative to the start codon) fused transcriptionally to <italic>lacZ</italic>. pGB215 and pGB217 were made by PCR-amplification from an <italic>E. coli</italic> MG1655 colony using primers JW5638 + JW9453 or JW5638 + JW9154, respectively, and cloning of the result PCR products into the <italic>Sph</italic>I and <italic>Nhe</italic>I sites of pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>). Plasmids pGB305 and pGB306 are equivalent to plasmids pGB215 and pGB217, except that they have a mutated <italic>rut</italic> in the 5′ UR (4C → 4A). They were constructed identically to pGB215 and pGB217 except that the PCRs used primers JW5638 + JW9453/JW9154, and the template for the PCR was plasmid pGB299. Plasmid pGB299 is a derivative of pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>) with the complete <italic>topAI</italic> gene (not including the stop codon) fused translationally to <italic>lacZ</italic>, with a mutated <italic>rut</italic> in the 5′ UR (4C → 4A). pGB299 was constructed by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW5638 + JW9803 and JW9804 + JW8023, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pAMD033 cut with <italic>Sph</italic>I and <italic>Hin</italic>dIII.</p>
<p>Plasmid pGB214 is equivalent to pJTW100 except that it has a mutation in the <italic>toiL</italic> start codon (ATG→gTa). pGB214 was constructed by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW5638 + JW9139 and JW9138 + JW5639, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant PCR product into pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>) cut with <italic>Sph</italic>I and <italic>Hin</italic>dIII. Plasmids pGB182 (wild-type) and pGB297 (<italic>toiL</italic> ATG→gTa) include the complete <italic>topAI</italic> 5′ UR transcriptionally fused to <italic>lacZ</italic>. pGB182 and pGB297 were made by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony or pGB214, respectively, using primers JW5638 + JW8809, and cloning the resultant PCR product into pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>) cut with <italic>Sph</italic>I and <italic>Nhe</italic>I.</p>
<p>Plasmid pGB164 is a derivative of pAMD033 with the full <italic>toiL</italic> gene (not including the stop codon) fused translationally to <italic>lacZ</italic>. Plasmids pGB196 (AAT→tga), pGB197 (CTG→tga), pGB200 (ATG→tga), and pGB201 (TTG→tga) are mutant derivatives of pGB164. pGB164 was made by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW5638 + JW8741, and cloning the resultant PCR product into pAMD033 (<xref ref-type="bibr" rid="c26">Dornenburg et al., 2010</xref>) cut with <italic>Sph</italic>I and <italic>Hin</italic>dIII. pGB196, pGB197, pGB200, and pGB201 were cloned identically except that primer JW8741 was replaced with JW8999, JW8998, JW9013, and JW9014, respectively.</p>
<p>Plasmid pGB202 is a derivative of pGB135 with a translational fusion of the <italic>topAI</italic> start codon to luciferase. pGB313 is a derivative of pGB202 with a <italic>toiL</italic> start codon mutation. pGB202 and pGB313 were made by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony or pGB214, respectively, using primers JW9288 + JW9289, and cloning the resultant PCR product into pGB135 cut with <italic>Bam</italic>HI and <italic>Eco</italic>RI. Plasmid pGB366 is a derivative of pGB202 with a <italic>toiL</italic> Shine-Dalgarno sequence mutation. pGB366 was made by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW9288 + JW10873 and JW10874 + JW9289, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pGB135 cut with <italic>Bam</italic>HI and <italic>Eco</italic>RI.</p>
<p>Plasmids pGB323, pGB324, pGB325, pGB326, pGB327, pGB328, pGB329, pGB346, and pGB347 include sequences that extend to different positions within <italic>toiL</italic> fused translationally to the <italic>ermCL</italic> gene from the 10<sup>th</sup> codon, which is fused translationally to luciferase. pGB323, pGB324, pGB325, pGB326, pGB327, pGB328, pGB329, pGB346, and pGB347 were made by PCR-amplifying (i) from an <italic>E. coli</italic> MG1655 colony using primer JW9288 and each of JW9989, JW10122, JW10144, JW10145, JW10146, JW10147, JW10148, JW101848, and JW10849, respectively, and (ii) from geneBlock GB007 (Supplementary Table 6) using primers JW10123 + JW9965. Pairs of PCR products were combined using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and the resultant products were cloned into pGB135 cut with <italic>Bam</italic>HI and <italic>Eco</italic>RI. pGB308 is equivalent to these plasmids except <italic>toiL</italic> coding sequence was replaced with the beginning of the <italic>ermCL</italic> sequence (codons 1-9). pGB308 was made by PCR-amplifying (i) from an <italic>E. coli</italic> MG1655 colony using primer JW9288 + JW9989, and (ii) from geneBlock GB007 (Table S6) using primers JW9990 + JW9965. Pairs of PCR products were combined using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and the resultant products were cloned into pGB135 cut with <italic>Bam</italic>HI and <italic>Eco</italic>RI.</p>
<p>Plasmids pGB322 and pGB318 are derivatives of pPro24 (<xref ref-type="bibr" rid="c43">Lee and Keasling, 2005</xref>), which contains a propionate-inducible promoter. pGB322 and pGB318 include a complete rRNA operon, either wild-type or mutant (ΔT1917 23S rRNA), respectively. The rRNA operons in both plasmids are fusions of the <italic>rrnB</italic> (upstream of 23S position +1917) and <italic>rrnC</italic> (position +1917 and downstream) operons. pGB318 was made first by PCR-amplifying from an <italic>E. coli</italic> MG1655 colony using primers JW10036 + JW9737 and JW9740 + JW10037, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pPro24 cut with <italic>Nhe</italic>I and <italic>Bam</italic>HI. pGB322 was made by PCR-amplifying from pGB318 using primers JW10036 + JW10104 and JW9740 + JW10105, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pPro24 cut with <italic>Nhe</italic>I and <italic>Bam</italic>HI.</p>
<p>Plasmid pGB72 is a derivative of pET-PesaRlux (<xref ref-type="bibr" rid="c74">Shong and Collins, 2013</xref>) that has a constitutive promoter (<xref ref-type="bibr" rid="c16">Burr et al., 2000</xref>) followed by 568 bp of a reverse-complemented <italic>Hin</italic>dIII fragment from the <italic>rrsB</italic> gene that is known to function as a Rho terminator (<xref ref-type="bibr" rid="c44">Li et al., 1984</xref>). pGB72 was made by annealing and extending primers JW7977b+7979b, PCR-amplifying from plasmid pSL103 (<xref ref-type="bibr" rid="c44">Li et al., 1984</xref>) using primers JW7994 and J7995, combining the two PCR products using splicing by overlap extension (<xref ref-type="bibr" rid="c33">Horton et al., 1990</xref>), and cloning the resultant product into pET-PesaRlux cut with <italic>Xho</italic>I and <italic>Bam</italic>HI.</p>
</sec>
<sec id="s4b">
<title>Isolation and identification of <italic>trans</italic>-acting mutants</title>
<p>The trans-acting mutant genetic selection was performed as described previously (<xref ref-type="bibr" rid="c7">Baniulyte et al., 2017</xref>). Briefly, cultures of MG1655 Δ<italic>lacZ</italic> with pJTW100 were grown at 37 °C in LB medium. 100 μl of overnight culture was washed and plated on M9 + 0.2% lactose agar. Spontaneous survivors were tested for increased plasmid copy number or <italic>cis</italic>-acting mutations near <italic>topAI</italic>; these mutants were eliminated. Chromosomal mutations were identified either by PCR-amplification and sequencing of <italic>rho</italic> or by whole-genome sequencing. Mutants identified this way included F62S, F62V, G63V (isolated three times), R66C, R66S, Y80C, Y80D, Y80N, Y80S, S82F (isolated twice), and P138L. Rho mutants were also detected by transducing a wild-type <italic>rho</italic> locus and looking for phenotypic reversion, or by introducing and assaying a Rho-dependent termination luciferase reporter plasmid (pGB72). Total genomic DNA was extracted from the three remaining mutants following the manufacturer’s protocol (Qiagen, catalog # 69504). SNPs were identified using whole-genome sequencing, as described previously (<xref ref-type="bibr" rid="c75">Singh et al., 2016</xref>).</p>
</sec>
<sec id="s4c">
<title>Quantification of RNAP association with DNA by chromatin immunoprecipitation coupled with real-time PCR (ChIP-qPCR)</title>
<p>20 ml <italic>E. coli</italic> wild-type (MG1655) or <italic>rho</italic> mutant (CRB016) cells were grown in LB at 37 °C with shaking. When the cultures reached an OD<sub>600</sub> of ∼1.0, tetracycline (Sigma #T3383) was added to one set of samples at a final concentration of 0.5 μg/ml. All untreated and tetracycline-treated samples (three biological replicates) were left at 37 °C with shaking for 17 min, after which 500 μl of each sample was pelleted and frozen for total RNA extraction later. For ChIP, the remainder of each sample was crosslinked with 1% formaldehyde (final concentration), and processed as previously described (<xref ref-type="bibr" rid="c78">Stringer et al., 2014</xref>). For immunoprecipitation, 800 μl of crosslinked chromatin was incubated with 25 μl Protein A Sepharose slurry (50%) in TBS and 1 μl of antibody against RNAP β (Biolegend, #663003, clone: NT63) for 90 minutes at room temperature while rotating. RNAP enrichment was normalized using the 2<sup>−ΔΔCt</sup> method to the corresponding “input” control sample and either the <italic>rhoL</italic> region (for measurements within <italic>rho</italic>) or the <italic>topAI</italic> promoter region (for measurements within <italic>topAI</italic>-<italic>yjhQP</italic>), as previously described (<xref ref-type="bibr" rid="c8">Bastet et al., 2017</xref>). All real-time PCR samples were set up in technical duplicates.</p>
</sec>
<sec id="s4d">
<title>Quantification of RNA levels by reverse transcription coupled with real-time PCR (RT-qPCR)</title>
<p>Total RNA was extracted from frozen pellets (see above) using a Quick-RNA Miniprep Kit (Zymo Research, #R1054) following the manufacturer’s protocol. Approximately 136 ng of total RNA for each sample was reverse-transcribed using MultiScribe Reverse Transcriptase (Invitrogen, #4311235) following the manufacturer’s protocol. A “no reverse transciptase” control was also included to assess DNA contamination. The resulting cDNA was diluted 1:3 and used as a template for quantitative real-time PCR. RNA expression values were obtained using the 2<sup>−ΔΔCt</sup> method, normalizing to a region within the <italic>mreB</italic> gene. Values were further normalized to those in wild-type cells (MG1655) without tetracycline treatment. All real-time PCR samples were set up in technical duplicates.</p>
</sec>
<sec id="s4e">
<title>RNA structural prediction using sequence identity among homologues</title>
<p>We used PETfold (<xref ref-type="bibr" rid="c71">Seemann et al., 2011</xref>, <xref ref-type="bibr" rid="c70">2008</xref>) to predict the <italic>topAI</italic> UR RNA secondary structure based on a sequence alignment of selected homologous sequences (<xref rid="fig6s1" ref-type="fig">Figure 6 – figure supplement 1A</xref>). All sequences are from species with at least 50% TopAI amino acid identity to the <italic>E. coli</italic> K-12 protein.</p>
</sec>
<sec id="s4f">
<title>SHAPE-seq</title>
<p>A total of three biological replicates of the strain GB001 + pJTW100 were grown to an OD<sub>600</sub> of ∼1.2 in LB medium at 37 °C. Cultures were split, and one set of two replicates was treated with 0.2 μg/ml tetracycline (T3383, Sigma) for 90 min. Cultures were subjected to the in-cell SHAPE-seq procedure previously described for poorly expressed mRNAs (<xref ref-type="bibr" rid="c91">Watters et al., 2016a</xref>). The SHAPE reagent 1M7 was purchased from MedChem Express (HY-D0913). SHAPE-seq libraries were sequenced using an Illumina MiSeq instrument (251 nt, paired-end reads). Sequencing data were analyzed using the <italic>spats</italic> pipeline (<xref ref-type="bibr" rid="c91">Watters et al., 2016a</xref>, <xref ref-type="bibr" rid="c92">2016b</xref>). Raw reactivities are listed in Table S3. Significant changes in reactivity and corresponding adjusted <italic>p</italic>-values upon tetracycline treatment were determined using the DESeq2 R package (<xref ref-type="bibr" rid="c46">Love et al., 2014</xref>), comparing untreated and tetracycline treated sample reactivities at each position using three (“Untreated”) and two (“Treated”) biological replicates from each sample. The mRNA structure of the <italic>topAI</italic> UR (<xref rid="fig6" ref-type="fig">Figure 6A</xref>) was predicted using mFOLD (<xref ref-type="bibr" rid="c99">Zuker, 2003</xref>) and drawn using StructureEditor (<ext-link ext-link-type="uri" xlink:href="https://rna.urmc.rochester.edu/GUI/html/StructureEditor.html">https://rna.urmc.rochester.edu/GUI/html/StructureEditor.html</ext-link>).</p>
</sec>
<sec id="s4g">
<title>Reporter assays</title>
<p>Bacterial cultures for luciferase or β-galactosidase assays were grown at 37 °C in LB medium to an OD<sub>600</sub> of 0.5–0.6 unless otherwise indicated in the figure legend. Cultures were grown in 15 ml round-bottom tubes except for antibiotic titration assays (Table S2; see below). Tetracycline (Sigma #T3383), spectinomycin (Sigma-Aldrich #S4014), erythromycin (Sigma-Aldrich #E5389), retapamulin (Sigma-Aldrich #CDS023386), tylosin (Sigma-Aldrich #T6134), chloramphenicol (Sigma-Aldrich #C0378), kasugamycin, gentamicin (Sigma-Aldrich #G1272), amikacin, streptomycin, apramycin, or hygromycin (Millipore #400052) antibiotics were added at indicated concentrations and timepoints. Reported epidemiological cut-off values for antibiotics reported by EUCAST (<xref ref-type="bibr" rid="c34">Kahlmeter and Turnidge, 2022</xref>) are: tetracycline, 8 μg/ml; spectinomycin, 64 μg/ml; chloramphenicol, 16 μg/ml; gentamicin, 2 μg/ml; amikacin, 8 μg/ml; streptomycin, 16 μg/ml. Minimum inhibitory concentrations have been reported for tylosin, 512 μg/ml (<xref ref-type="bibr" rid="c4">Andersen et al., 2012</xref>); kasugamycin, 500 μg/ml (<xref ref-type="bibr" rid="c41">Lange et al., 2017</xref>); erythromycin, 150 μg/ml (<xref ref-type="bibr" rid="c81">Suvorov et al., 1988</xref>); apramycin, 32 μg/ml (<xref ref-type="bibr" rid="c98">Yang et al., 2020</xref>); retapamulin, 12.5 μg/ml (<xref ref-type="bibr" rid="c54">Meydan et al., 2019</xref>); and hygromycin, 150 μg/ml (<xref ref-type="bibr" rid="c53">McGaha and Champney, 2007</xref>).</p>
<p>Plasmid-encoded wild-type and mutant rRNA overexpression (<xref rid="fig2" ref-type="fig">Figure 2B</xref>) was induced by adding 12 mM sodium propionate (Sigma-Aldrich #P1880) to bacterial cultures at an OD<sub>600</sub> of ∼0.2. β-galactosidase assays were performed as previously described (<xref ref-type="bibr" rid="c7">Baniulyte et al., 2017</xref>). For luciferase assays, each cell culture (200 μl) was aliquoted into a 96-well plate with four technical replicates each. Luminescence readings for were taken using a Biotek Synergy 2 instrument. Luminescence counts (RLU) were adjusted for OD<sub>600</sub> and reported as RLU/OD<sub>600</sub>. Antibiotic concentrations and lengths of treatments are indicated in the figure legends. Antibiotic titration assays (Table S2) were performed in 96-well deep-well plates. Briefly, 1.5 ml of GB001 cells containing the pGB202 plasmid was grown to an OD<sub>600</sub> of ∼1.0, aliquoted into a 96-well deep-well plate, and treated with antibiotics at the indicated concentrations for 90 min. 100 μL of each bacterial culture was used for luminescence detection, as described above.</p>
</sec>
<sec id="s4h">
<title>Ribosome profiling (Ribo-seq)</title>
<p>200 ml of <italic>E. coli</italic> MG1655 cells were grown in LB ± 1 μg/ml tetracycline to an OD<sub>600</sub> of ∼1.1. Filtering was started at 17 min post-treatment. Monosomes were isolated and libraries were constructed as previously described (<xref ref-type="bibr" rid="c76">Smith et al., 2022</xref>), with minor modifications: the 3’-linked oligonucleotide ligation reaction was carried out overnight at 16 °C; circularized, reverse-transcribed cDNA was PCR-amplified for 6-8 cycles using universal primer JW8835 and sample-specific primers JW3249 (no antibiotic) or JW10755 (tetracycline).</p>
<p>Determination of Ribo-seq sequence read coverage was performed as described previously (<xref ref-type="bibr" rid="c76">Smith et al., 2022</xref>). Briefly, sequence reads were trimmed using a custom Python script to remove the ligated adaptor sequence, and mapped to reference genome MG1655 NC_000913.3 using Rockhopper (<xref ref-type="bibr" rid="c52">McClure et al., 2013</xref>). Sequence read coverage for sequence 3’ ends (presumed to correspond to the positions of the downstream edge of ribosomes) was determined for the whole genome, normalizing to total read count (reads per million; RPM). The metagene plot showing sequence read coverage around start codons (<xref rid="fig7" ref-type="fig">Figure 7C</xref>) was generated as described previously (<xref ref-type="bibr" rid="c76">Smith et al., 2022</xref>). Normalized Ribo-seq coverage for all annotated ORFs was determined using differential expression analysis with Rockhopper (<xref ref-type="bibr" rid="c52">McClure et al., 2013</xref>), excluding the first and last 30 nt of each gene.</p>
</sec>
</sec>

</body>
<back>
<sec id="s7">
<fig id="fig2s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2, Figure Supplement 1.</label>
<caption><title><italic>topAI</italic> is translationally repressed.</title>
<p><bold>(A)</bold> Schematic representation of the <italic>topAI</italic>-<italic>lux</italic> translational reporter fusion. <bold>(B)</bold> Luciferase activity of the <italic>topAI</italic>-<italic>lux</italic> translational fusion (plasmid pGB202) in Δ<italic>topAI</italic>-<italic>yjhQ</italic> cells (“Wild-type”; strain GB001) or in Δ<italic>topAI</italic>-<italic>yjhQ rho</italic> mutant (R66S amino acid substitution in Rho; strain GB004). Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig2s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig4s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4, Figure Supplement 1.</label>
<caption><title>ToiL conservation across <italic>Enterobacteriaceae</italic> species.</title>
<p>Predicted ToiL sequences were aligned with ClustalO (<xref ref-type="bibr" rid="c48">Madeira et al., 2022</xref>). Asterisks indicate fully conserved positions.</p></caption>
<graphic xlink:href="682021v4_fig4s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5, Figure Supplement 1.</label>
<caption><title>Mutation of the <italic>toiL</italic> start codon does not alter predicted RNA secondary structure and does not lead to Rho-dependent transcription termination in the <italic>topAI</italic> 5’ upstream region.</title>
<p><bold>(A)</bold> Predicted minimum free-energy secondary structures of the <italic>topAI</italic> 5’ UR for wild-type sequence and sequence where the <italic>toiL</italic> start codon (ATG) is mutated (GTA). <bold>(B)</bold> Schematic representation of <italic>topAI</italic>-<italic>lacZ</italic> transcriptional reporter fusions indicating the start codon mutation of <italic>toiL</italic>. <bold>(C)</bold> β-galactosidase activity of the wild-type <italic>topAI</italic>-<italic>lacZ</italic> transcriptional reporter (plasmid pGB182) and the <italic>toiL</italic> start codon mutant reporter (plasmid pGB297) in Δ<italic>topAI-yjhQ</italic> cells (strain GB001). Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig5s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig6s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6, Figure Supplement 1.</label>
<caption><title>Predicted RNA secondary structure for the <italic>topAI</italic> upstream region based on sequence conservation</title>
<p><bold>(A)</bold> PETfold alignment of <italic>topAI</italic> 5’ UR sequences from selected species. Predicted base pairing interactions are represented in a dot-bracket format below the alignment. Reliability of base pairing (reliab_paired) and sequence conservation scores are represented as grey bars (0 - 1 scale). <bold>(B)</bold> Representation of the PETfold-predicted <italic>topAI</italic> 5’ UR RNA consensus structure. Nucleotide colors in both panels follow the Vienna RNA conservation coloring schema (<xref ref-type="bibr" rid="c11">Bernhart et al., 2008</xref>) and represent the number of compatible or incompatible nucleotide pairs for each position, as indicated.</p></caption>
<graphic xlink:href="682021v4_fig6s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig8s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8, Figure Supplement 1.</label>
<caption><title>Predicted RNA structures for translationally inactive and active conformations of <italic>toiL</italic> stalling reporters.</title>
<p>Predicted RNA structures are shown for <italic>toiL</italic>-<italic>ermCL</italic>-<italic>lux</italic> stalling reporters where increasing lengths of <italic>toiL</italic> are fused to part of <italic>ermCL</italic>. <italic>toiL</italic> is indicated by red arrows. <italic>ermCL</italic> sequence is indicated by green arrows. Pausing of ribosomes within <italic>toiL</italic>, close to the junction with <italic>ermCL</italic> sequence, is expected to promote formation of the active (“ON”) conformation, whereas the absence of ribosome stalling within <italic>toiL</italic> is expected to promote formation of the inactive (“OFF”) conformation.</p></caption>
<graphic xlink:href="682021v4_fig8s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig8s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8, Figure Supplement 2.</label>
<caption><title>Expression of an <italic>ermCL</italic> stalling reporter is specifically induced by erythromycin.</title>
<p><bold>(A)</bold> Schematic showing the <italic>ermCL</italic>-<italic>lux</italic> stalling reporter in the translationally inactive conformation (“OFF”) that is expected in the absence of erythromycin, and the translationally active conformation (“ON”) that is expected when ribosomes stall within <italic>ermCL</italic> in the presence of erythromycin. <bold>(B)</bold> Predicted RNA secondary structures of the inactive (“OFF”) and active (“ON”) conformations of the <italic>ermCL</italic>-<italic>lux</italic> stalling reporter. <bold>(C)</bold> Luciferase activity of the <italic>ermCL</italic>-<italic>lux</italic> stalling reporter (plasmid pGB308) in Δ<italic>topAI-yjhQ</italic> cells (strain GB001) treated with the indicated ribosome-targeting antibiotics. Cells were grown to an OD<sub>600</sub> of ∼1.0 and treated with the indicated ribosome-targeting antibiotics at the same concentrations as in <xref rid="fig2" ref-type="fig">Figure 2C</xref>. Luminescence was measured three hours post-treatment. Error bars represent ±1 standard deviation from the mean (n = 3).</p></caption>
<graphic xlink:href="682021v4_fig8s2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability</title>
<p>Raw Illumina sequencing data are available from EBI ArrayExpress using accession numbers E-MTAB-8365 (SHAPE-seq) and E-MTAB-12242 (Ribo-seq).</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We thank Randall Morse, Pan Li, and Allen Buskirk for helpful comments on the manuscript. We thank the Wadsworth Center Applied Genomic Technologies Core Facility for DNA sequencing. We thank the Wadsworth Center Tissue Culture and Media Core Facility and Glassware Facility for technical support.</p>
</ack>
<sec id="d1e2686" sec-type="additional-information">
<title>Additional information</title>
<sec id="s5">
<title>Funding information</title>
<p>This work was supported in part by the NIH Director’s New Innovator Award Program, 1DP2OD007188 (J.T.W.) and National Institutes of Health grant 1R35GM144328 (J.T.W.).</p>
</sec>
</sec>
<sec id="suppd1e2686" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="d1e2677">
<label>Supplementary Tables 1-6</label>
<media xlink:href="supplements/682021_file17.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adams</surname> <given-names>PP</given-names></string-name>, <string-name><surname>Baniulyte</surname> <given-names>G</given-names></string-name>, <string-name><surname>Esnault</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chegireddy</surname> <given-names>K</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Monge</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dale</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Storz</surname> <given-names>G</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2021</year>. <article-title>Regulatory roles of Escherichia coli 5’ UTR and ORF-internal RNAs detected by 3’ end mapping</article-title>. <source>eLife</source> <volume>10</volume>:<elocation-id>e62438</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.62438</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adhya</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gottesman</surname> <given-names>M</given-names></string-name></person-group>. <year>1978</year>. <article-title>Control of Transcription Termination</article-title>. <source>Annual Review of Biochemistry</source> <volume>47</volume>:<fpage>967</fpage>–<lpage>996</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.bi.47.070178.004535</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alifano</surname> <given-names>P</given-names></string-name>, <string-name><surname>Rivellini</surname> <given-names>F</given-names></string-name>, <string-name><surname>Limauro</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bruni</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Carlomagno</surname> <given-names>MS</given-names></string-name></person-group>. <year>1991</year>. <article-title>A consensus motif common to all rho-dependent prokaryotic transcription terminators</article-title>. <source>Cell</source> <volume>64</volume>:<fpage>553</fpage>–<lpage>563</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0092-8674(91)90239-U</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersen</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Poehlsgaard</surname> <given-names>J</given-names></string-name>, <string-name><surname>Warrass</surname> <given-names>R</given-names></string-name>, <string-name><surname>Douthwaite</surname> <given-names>S</given-names></string-name></person-group>. <year>2012</year>. <article-title>Inhibition of protein synthesis on the ribosome by tildipirosin compared with other veterinary macrolides</article-title>. <source>Antimicrob Agents Chemother</source> <volume>56</volume>:<fpage>6033</fpage>–<lpage>6036</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01250-12</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baek</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yoon</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>H</given-names></string-name></person-group>. <year>2017</year>. <article-title>Identification of Unannotated Small Genes in Salmonella</article-title>. <source>G3: Genes, Genomes, Genetics</source> <volume>7</volume>:<fpage>983</fpage>–<lpage>989</lpage>. doi:<pub-id pub-id-type="doi">10.1534/g3.116.036939</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chettiath</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2008</year>. <article-title>Induction of erm(C) expression by noninducing antibiotics</article-title>. <source>Antimicrobial Agents and Chemotherapy</source> <volume>52</volume>:<fpage>866</fpage>–<lpage>874</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01266-07</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baniulyte</surname> <given-names>G</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Benoit</surname> <given-names>C</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ferguson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Paramo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Stringer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lapierre</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2017</year>. <article-title>Identification of regulatory targets for the bacterial Nus factor complex</article-title>. <source>Nature Communications</source> <volume>8</volume>:<fpage>2027</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-017-02124-9</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bastet</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chauvier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lussier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lamontagne</surname> <given-names>A-M</given-names></string-name>, <string-name><surname>Prévost</surname> <given-names>K</given-names></string-name>, <string-name><surname>Massé</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Lafontaine</surname> <given-names>DA</given-names></string-name></person-group>. <year>2017</year>. <article-title>Translational control and Rho-dependent transcription termination are intimately linked in riboswitch regulation</article-title>. <source>Nucleic Acids Research</source> <volume>45</volume>:<fpage>7474</fpage>–<lpage>7486</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkx434</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bastet</surname> <given-names>L</given-names></string-name>, <string-name><surname>Turcotte</surname> <given-names>P</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Lafontaine</surname> <given-names>DA</given-names></string-name></person-group>. <year>2018</year>. <article-title>Maestro of regulation: Riboswitches orchestrate gene expression at the levels of translation, transcription and mRNA decay</article-title>. <source>RNA Biol</source> <volume>15</volume>:<fpage>679</fpage>–<lpage>682</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15476286.2018.1451721</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ben-Zvi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Pushkarev</surname> <given-names>A</given-names></string-name>, <string-name><surname>Seri</surname> <given-names>H</given-names></string-name>, <string-name><surname>Elgrably-Weiss</surname> <given-names>M</given-names></string-name>, <string-name><surname>Papenfort</surname> <given-names>K</given-names></string-name>, <string-name><surname>Altuvia</surname> <given-names>S</given-names></string-name></person-group>. <year>2019</year>. <article-title>mRNA dynamics and alternative conformations adopted under low and high arginine concentrations control polyamine biosynthesis in Salmonella</article-title>. <source>PLoS Genetics</source> <volume>15</volume>:<fpage>e1007646</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1007646</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bernhart</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Hofacker</surname> <given-names>IL</given-names></string-name>, <string-name><surname>Will</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gruber</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Stadler</surname> <given-names>PF</given-names></string-name></person-group>. <year>2008</year>. <article-title>RNAalifold: improved consensus structure prediction for RNA alignments</article-title>. <source>BMC Bioinformatics</source> <volume>9</volume>:<fpage>474</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-2105-9-474</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bossi</surname> <given-names>L</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Guillemardet</surname> <given-names>B</given-names></string-name>, <string-name><surname>Boudvillain</surname> <given-names>M</given-names></string-name>, <string-name><surname>Figueroa-Bossi</surname> <given-names>N</given-names></string-name></person-group>. <year>2012</year>. <article-title>A role for Rho-dependent polarity in gene regulation by a noncoding small RNA</article-title>. <source>Genes and Development</source> <volume>26</volume>:<fpage>1864</fpage>–<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.195412.112</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breaker</surname> <given-names>RR</given-names></string-name></person-group>. <year>2018</year>. <article-title>Riboswitches and Translation Control</article-title>. <source>Cold Spring Harbor perspectives in biology</source> <volume>10</volume>:<fpage>a032797</fpage>. doi:<pub-id pub-id-type="doi">10.1101/cshperspect.a032797</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burian</surname> <given-names>J</given-names></string-name>, <string-name><surname>Thompson</surname> <given-names>CJ</given-names></string-name></person-group>. <year>2018</year>. <article-title>Regulatory genes coordinating antibiotic-induced changes in promoter activity and early transcriptional termination of the mycobacterial intrinsic resistance gene whiB7</article-title>. <source>Mol Microbiol</source> <volume>107</volume>:<fpage>402</fpage>–<lpage>415</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.13890</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burmann</surname> <given-names>BM</given-names></string-name>, <string-name><surname>Schweimer</surname> <given-names>K</given-names></string-name>, <string-name><surname>Luo</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wahl</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Stitt</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Gottesman</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Rosch</surname> <given-names>P</given-names></string-name></person-group>. <year>2010</year>. <article-title>A NusE:NusG Complex Links Transcription and Translation</article-title>. <source>Science</source> <volume>328</volume>:<fpage>501</fpage>–<lpage>504</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1184953</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burr</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kolb</surname> <given-names>A</given-names></string-name>, <string-name><surname>Minchin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Busby</surname> <given-names>S</given-names></string-name></person-group>. <year>2000</year>. <article-title>DNA sequence elements located immediately upstream of the −10 hexamer in Escherichia coli promoters: a systematic study</article-title>. <source>Nucleic acids research</source> <volume>28</volume>:<fpage>1864</fpage>–<lpage>70</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cardinale</surname> <given-names>CJ</given-names></string-name>, <string-name><surname>Washburn</surname> <given-names>RS</given-names></string-name>, <string-name><surname>Tadigotla</surname> <given-names>VR</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Gottesman</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Nudler</surname> <given-names>E</given-names></string-name></person-group>. <year>2008</year>. <article-title>Termination factor Rho and its cofactors NusA and NusG silence foreign DNA in E. coli</article-title>. <source>Science (New York, NY)</source> <volume>320</volume>:<fpage>935</fpage>–<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1152763</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chhakchhuak</surname> <given-names>PIR</given-names></string-name>, <string-name><surname>Khatri</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sen</surname> <given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title>Mechanism of Action of Bacterial Transcription Terminator Rho</article-title>. <source>Proceedings of the Indian National Science Academy</source>. doi:<pub-id pub-id-type="doi">10.16943/ptinsa/2018/49436</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chopra</surname> <given-names>I</given-names></string-name>, <string-name><surname>Roberts</surname> <given-names>M</given-names></string-name></person-group>. <year>2001</year>. <article-title>Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance</article-title>. <source>Microbiology and Molecular Biology Reviews</source>. doi:<pub-id pub-id-type="doi">10.1128/mmbr.65.2.232-260.2001</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dar</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sorek</surname> <given-names>R</given-names></string-name></person-group>. <year>2018</year>. <article-title>High-resolution RNA 3-ends mapping of bacterial Rho-dependent transcripts</article-title>. <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gky274</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Davis</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Gohara</surname> <given-names>DW</given-names></string-name>, <string-name><surname>Yap</surname> <given-names>M-NF</given-names></string-name></person-group>. <year>2014</year>. <article-title>Sequence selectivity of macrolide-induced translational attenuation</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>111</volume>:<fpage>15379</fpage>–<lpage>15384</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1410356111</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Smit</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Verlaan</surname> <given-names>PWG</given-names></string-name>, <string-name><surname>van Duin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pleij</surname> <given-names>CWA.</given-names></string-name></person-group> <year>2009</year>. <article-title>In Vivo Dynamics of Intracistronic Transcriptional Polarity</article-title>. <source>Journal of Molecular Biology</source> <volume>385</volume>:<fpage>733</fpage>–<lpage>747</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2008.11.020</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Smit</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Verlaan</surname> <given-names>PWG</given-names></string-name>, <string-name><surname>van Duin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pleij</surname> <given-names>CWA.</given-names></string-name></person-group> <year>2008</year>. <article-title>Intracistronic transcriptional polarity enhances translational repression: a new role for Rho</article-title>. <source>Molecular microbiology</source> <volume>69</volume>:<fpage>1278</fpage>–<lpage>89</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Deana</surname> <given-names>A</given-names></string-name>, <string-name><surname>Belasco</surname> <given-names>JG</given-names></string-name></person-group>. <year>2005</year>. <article-title>Lost in translation: the influence of ribosomes on bacterial mRNA decay</article-title>. <source>Genes Dev</source> <volume>19</volume>:<fpage>2526</fpage>–<lpage>2533</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.1348805</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="preprint"><person-group person-group-type="author"><string-name><surname>D’Halluin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Polgar</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kipkorir</surname> <given-names>T</given-names></string-name>, <string-name><surname>Patel</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Cortes</surname> <given-names>T</given-names></string-name>, <string-name><surname>Arnvig</surname> <given-names>KB</given-names></string-name></person-group>. <year>2022</year>. <article-title>Term-seq reveals an abundance of conditional, Rho-dependent termination in Mycobacterium tuberculosis</article-title>. <source>bioRxiv</source> doi:<pub-id pub-id-type="doi">10.1101/2022.06.01.494293</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dornenburg</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Devita</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Palumbo</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2010</year>. <article-title>Widespread antisense transcription in Escherichia coli</article-title>. <source>mBio</source> <volume>1</volume>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00024-10</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dzyubak</surname> <given-names>E</given-names></string-name>, <string-name><surname>Yap</surname> <given-names>M-NF</given-names></string-name></person-group>. <year>2016</year>. <article-title>The expression of antibiotic resistance methyltransferase correlates with mRNA stability independently of ribosome stalling</article-title>. <source>Antimicrobial Agents and Chemotherapy</source> <volume>60</volume>:<fpage>AAC.01806</fpage>–<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01806-16</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Feinberg</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Joseph</surname> <given-names>S</given-names></string-name></person-group>. <year>2006</year>. <article-title>A Conserved Base-pair between tRNA and 23 S rRNA in the Peptidyl Transferase Center Is Important for Peptide Release</article-title>. <source>Journal of Molecular Biology</source>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2006.09.040</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fostier</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Ousalem</surname> <given-names>F</given-names></string-name>, <string-name><surname>Leroy</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Ngo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Soufari</surname> <given-names>H</given-names></string-name>, <string-name><surname>Innis</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Hashem</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Boël</surname> <given-names>G</given-names></string-name></person-group>. <year>2023</year>. <article-title>Regulation of the macrolide resistance ABC-F translation factor MsrD</article-title>. <source>Nat Commun</source> <volume>14</volume>:<fpage>3891</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-023-39553-8</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gregory</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Lieberman</surname> <given-names>KR</given-names></string-name>, <string-name><surname>Dahlberg</surname> <given-names>AE</given-names></string-name></person-group>. <year>1994</year>. <article-title>Mutations in the peptidyl transferase region of E. coli 23S rRNA affecting translational accuracy</article-title>. <source>Nucleic acids research</source> <volume>22</volume>:<fpage>279</fpage>–<lpage>84</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herrero Del Valle</surname> <given-names>A</given-names></string-name>, <string-name><surname>Seip</surname> <given-names>B</given-names></string-name>, <string-name><surname>Cervera-Marzal</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sacheau</surname> <given-names>G</given-names></string-name>, <string-name><surname>Seefeldt</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Innis</surname> <given-names>CA.</given-names></string-name></person-group> <year>2020</year>. <article-title>Ornithine capture by a translating ribosome controls bacterial polyamine synthesis</article-title>. <source>Nat Microbiol</source> <volume>5</volume>:<fpage>554</fpage>–<lpage>561</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41564-020-0669-1</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirabayashi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>NS</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>T</given-names></string-name></person-group>. <year>2006</year>. <article-title>Conserved loop sequence of helix 69 in Escherichia coli 23 S rRNA is involved in A-site tRNA binding and translational fidelity</article-title>. <source>The Journal of biological chemistry</source> <volume>281</volume>:<fpage>17203</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M511728200</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horton</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Cai</surname> <given-names>ZL</given-names></string-name>, <string-name><surname>Ho</surname> <given-names>SN</given-names></string-name>, <string-name><surname>Pease</surname> <given-names>LR</given-names></string-name></person-group>. <year>1990</year>. <article-title>Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction</article-title>. <source>BioTechniques</source> <volume>8</volume>:<fpage>528</fpage>–<lpage>535</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kahlmeter</surname> <given-names>G</given-names></string-name>, <string-name><surname>Turnidge</surname> <given-names>J</given-names></string-name></person-group>. <year>2022</year>. <article-title>How to: ECOFFs-the why, the how, and the don’ts of EUCAST epidemiological cutoff values</article-title>. <source>Clin Microbiol Infect</source> <volume>28</volume>:<fpage>952</fpage>–<lpage>954</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cmi.2022.02.024</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kipper</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hetényi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Sild</surname> <given-names>S</given-names></string-name>, <string-name><surname>Remme</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liiv</surname> <given-names>A</given-names></string-name></person-group>. <year>2009</year>. <article-title>Ribosomal intersubunit bridge B2a is involved in factor-dependent translation initiation and translational processivity</article-title>. <source>J Mol Biol</source> <volume>385</volume>:<fpage>405</fpage>–<lpage>422</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2008.10.065</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kipper</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sild</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hetényi</surname> <given-names>C</given-names></string-name>, <string-name><surname>Remme</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liiv</surname> <given-names>A</given-names></string-name></person-group>. <year>2011</year>. <article-title>Pseudouridylation of 23S rRNA helix 69 promotes peptide release by release factor RF2 but not by release factor RF1</article-title>. <source>Biochimie</source>. doi:<pub-id pub-id-type="doi">10.1016/j.biochi.2010.12.018</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kohanski</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Dwyer</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Wierzbowski</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cottarel</surname> <given-names>G</given-names></string-name>, <string-name><surname>Collins</surname> <given-names>JJ</given-names></string-name></person-group>. <year>2008</year>. <article-title>Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death</article-title>. <source>Cell</source> <volume>135</volume>:<fpage>679</fpage>–<lpage>90</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.038</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kriner</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Groisman</surname> <given-names>EA</given-names></string-name></person-group>. <year>2017</year>. <article-title>RNA secondary structures regulate three steps of Rho-dependent transcription termination within a bacterial mRNA leader</article-title>. <source>Nucleic Acids Research</source> <volume>45</volume>:<fpage>631</fpage>–<lpage>642</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkw889</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kriner</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Sevostyanova</surname> <given-names>A</given-names></string-name>, <string-name><surname>Groisman</surname> <given-names>EA</given-names></string-name></person-group>. <year>2016</year>. <article-title>Learning from the Leaders: Gene Regulation by the Transcription Termination Factor Rho</article-title>. <source>Trends in biochemical sciences</source> <volume>41</volume>:<fpage>690</fpage>–<lpage>699</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2016.05.012</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Landick</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yanofsky</surname> <given-names>C</given-names></string-name></person-group>. <year>1987</year>. <article-title>Transcription Attenuation</article-title>. <source>American Society for Microbiology</source> <volume>1</volume>:<fpage>1276</fpage>–<lpage>1301</lpage>.</mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lange</surname> <given-names>C</given-names></string-name>, <string-name><surname>Lehr</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zerulla</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ludwig</surname> <given-names>P</given-names></string-name>, <string-name><surname>Schweitzer</surname> <given-names>J</given-names></string-name>, <string-name><surname>Polen</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wendisch</surname> <given-names>VF</given-names></string-name>, <string-name><surname>Soppa</surname> <given-names>J</given-names></string-name></person-group>. <year>2017</year>. <article-title>Effects of Kasugamycin on the Translatome of Escherichia coli</article-title>. <source>PLoS One</source> <volume>12</volume>:<fpage>e0168143</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0168143</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>J-H</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>E-J</given-names></string-name>, <string-name><surname>Roe</surname> <given-names>J-H</given-names></string-name></person-group>. <year>2022</year>. <article-title>uORF-mediated riboregulation controls transcription of whiB7/wblC antibiotic resistance gene</article-title>. <source>Molecular Microbiology</source> <volume>117</volume>:<fpage>179</fpage>–<lpage>192</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.14834</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Keasling</surname> <given-names>JD</given-names></string-name></person-group>. <year>2005</year>. <article-title>A propionate-inducible expression system for enteric bacteria</article-title>. <source>Applied and environmental microbiology</source>. doi:<pub-id pub-id-type="doi">10.1128/AEM.71.11.6856-6862.2005</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Squires</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Squires</surname> <given-names>C</given-names></string-name></person-group>. <year>1984</year>. <article-title>Antitermination of E. coli rRNA transcription is caused by a control region segment containing lambda nut-like sequences</article-title>. <source>Cell</source> <volume>38</volume>:<fpage>851</fpage>–<lpage>60</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liiv</surname> <given-names>A</given-names></string-name>, <string-name><surname>Karitkina</surname> <given-names>D</given-names></string-name>, <string-name><surname>Maiväli</surname> <given-names>Ü</given-names></string-name>, <string-name><surname>Remme</surname> <given-names>J</given-names></string-name></person-group>. <year>2005</year>. <article-title>Analysis of the function of E. coli 23S rRNA helix-loop 69 by mutagenesis</article-title>. <source>BMC Molecular Biology</source>. doi:<pub-id pub-id-type="doi">10.1186/1471-2199-6-18</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Love</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Huber</surname> <given-names>W</given-names></string-name>, <string-name><surname>Anders</surname> <given-names>S</given-names></string-name></person-group>. <year>2014</year>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome biology</source> <volume>15</volume>:<fpage>550</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lybecker</surname> <given-names>M</given-names></string-name>, <string-name><surname>Zimmermann</surname> <given-names>B</given-names></string-name>, <string-name><surname>Bilusic</surname> <given-names>I</given-names></string-name>, <string-name><surname>Tukhtubaeva</surname> <given-names>N</given-names></string-name>, <string-name><surname>Schroeder</surname> <given-names>R</given-names></string-name></person-group>. <year>2014</year>. <article-title>The double-stranded transcriptome of Escherichia coli</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>111</volume>:<fpage>3134</fpage>–<lpage>3139</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1315974111</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Madeira</surname> <given-names>F</given-names></string-name>, <string-name><surname>Pearce</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tivey</surname> <given-names>ARN</given-names></string-name>, <string-name><surname>Basutkar</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>J</given-names></string-name>, <string-name><surname>Edbali</surname> <given-names>O</given-names></string-name>, <string-name><surname>Madhusoodanan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kolesnikov</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lopez</surname> <given-names>R</given-names></string-name></person-group>. <year>2022</year>. <article-title>Search and sequence analysis tools services from EMBL-EBI in 2022</article-title>. <source>Nucleic Acids Res</source> <volume>50</volume>:<fpage>W276</fpage>–<lpage>W279</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkac240</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>Y</given-names></string-name></person-group>. <year>2015</year>. <article-title>Revisiting operons: an analysis of the landscape of transcriptional units in E. coli</article-title>. <source>BMC Bioinformatics</source> <volume>16</volume>:<fpage>356</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12859-015-0805-8</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martinez</surname> <given-names>A</given-names></string-name>, <string-name><surname>Opperman</surname> <given-names>T</given-names></string-name>, <string-name><surname>Richardson</surname> <given-names>JP</given-names></string-name></person-group>. <year>1996</year>. <article-title>Mutational analysis and secondary structure model of the RNP1-like sequence motif of transcription termination factor Rho</article-title>. <source>Journal of Molecular Biology</source> <volume>257</volume>:<fpage>895</fpage>–<lpage>908</lpage>. doi:<pub-id pub-id-type="doi">10.1006/jmbi.1996.0210</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matsumoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Shigesada</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hirano</surname> <given-names>M</given-names></string-name>, <string-name><surname>Imai</surname> <given-names>M</given-names></string-name></person-group>. <year>1986</year>. <article-title>Autogenous regulation of the gene for transcription termination factor rho in Escherichia coli: localization and function of its attenuators</article-title>. <source>Journal of bacteriology</source> <volume>166</volume>:<fpage>945</fpage>–<lpage>58</lpage>.</mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McClure</surname> <given-names>R</given-names></string-name>, <string-name><surname>Balasubramanian</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Bobrovskyy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sumby</surname> <given-names>P</given-names></string-name>, <string-name><surname>Genco</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Vanderpool</surname> <given-names>CK</given-names></string-name>, <string-name><surname>Tjaden</surname> <given-names>B</given-names></string-name></person-group>. <year>2013</year>. <article-title>Computational analysis of bacterial RNA-Seq data</article-title>. <source>Nucleic Acids Res</source> <volume>41</volume>:<fpage>e140</fpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>McGaha</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Champney</surname> <given-names>WS</given-names></string-name></person-group>. <year>2007</year>. <article-title>Hygromycin B inhibition of protein synthesis and ribosome biogenesis in Escherichia coli</article-title>. <source>Antimicrob Agents Chemother</source> <volume>51</volume>:<fpage>591</fpage>–<lpage>596</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01116-06</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meydan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Marks</surname> <given-names>J</given-names></string-name>, <string-name><surname>Klepacki</surname> <given-names>D</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>V</given-names></string-name>, <string-name><surname>Baranov</surname> <given-names>PV</given-names></string-name>, <string-name><surname>Firth</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Margus</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kefi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vázquez-Laslop</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2019</year>. <article-title>Retapamulin-Assisted Ribosome Profiling Reveals the Alternative Bacterial Proteome</article-title>. <source>Molecular Cell</source> <volume>74</volume>:<fpage>481</fpage>–<lpage>493</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.017</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nadiras</surname> <given-names>C</given-names></string-name>, <string-name><surname>Eveno</surname> <given-names>E</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Figueroa-Bossi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Boudvillain</surname> <given-names>M</given-names></string-name></person-group>. <year>2018</year>. <article-title>A multivariate prediction model for Rho-dependent termination of transcription</article-title>. <source>Nucleic Acids Research</source> <volume>46</volume>:<fpage>8245</fpage>–<lpage>8260</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gky563</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakahigashi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Takai</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kimura</surname> <given-names>M</given-names></string-name>, <string-name><surname>Abe</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nakayashiki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Shiwa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yoshikawa</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wanner</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Ishihama</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>H</given-names></string-name></person-group>. <year>2016</year>. <article-title>Comprehensive identification of translation start sites by tetracycline-inhibited ribosome profiling</article-title>. <source>DNA Research</source> <volume>23</volume>:<fpage>193</fpage>–<lpage>201</lpage>. doi:<pub-id pub-id-type="doi">10.1093/dnares/dsw008</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nguyen</surname> <given-names>F</given-names></string-name>, <string-name><surname>Starosta</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Arenz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sohmen</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dönhöfer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>DN</given-names></string-name></person-group>. <year>2014</year>. <article-title>Tetracycline antibiotics and resistance mechanisms</article-title>. <source>Biol Chem</source> <volume>395</volume>:<fpage>559</fpage>–<lpage>575</lpage>. doi:<pub-id pub-id-type="doi">10.1515/hsz-2013-0292</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Obana</surname> <given-names>N</given-names></string-name>, <string-name><surname>Takada</surname> <given-names>H</given-names></string-name>, <string-name><surname>Crowe-McAuliffe</surname> <given-names>C</given-names></string-name>, <string-name><surname>Iwamoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Egorov</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>KJY</given-names></string-name>, <string-name><surname>Chiba</surname> <given-names>S</given-names></string-name>, <string-name><surname>Murina</surname> <given-names>V</given-names></string-name>, <string-name><surname>Paternoga</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tresco</surname> <given-names>BIC</given-names></string-name>, <string-name><surname>Nomura</surname> <given-names>N</given-names></string-name>, <string-name><surname>Myers</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Atkinson</surname> <given-names>GC</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>DN</given-names></string-name>, <string-name><surname>Hauryliuk</surname> <given-names>V</given-names></string-name></person-group>. <year>2023</year>. <article-title>Genome-encoded ABCF factors implicated in intrinsic antibiotic resistance in Gram-positive bacteria: VmlR2, Ard1 and CplR</article-title>. <source>Nucleic Acids Res</source> <fpage>gkad193</fpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkad193</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orelle</surname> <given-names>C</given-names></string-name>, <string-name><surname>Carlson</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kaushal</surname> <given-names>B</given-names></string-name>, <string-name><surname>Almutairi</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ochabowicz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Quan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pham</surname> <given-names>VC</given-names></string-name>, <string-name><surname>Squires</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Murphy</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2013</year>. <article-title>Tools for Characterizing Bacterial Protein Synthesis Inhibitors</article-title>. <source>Antimicrobial Agents and Chemotherapy</source> <volume>57</volume>:<fpage>5994</fpage>–<lpage>6004</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.01673-13</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Osterman</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Prokhorova</surname> <given-names>IV</given-names></string-name>, <string-name><surname>Sysoev</surname> <given-names>VO</given-names></string-name>, <string-name><surname>Boykova</surname> <given-names>YV</given-names></string-name>, <string-name><surname>Efremenkova</surname> <given-names>OV</given-names></string-name>, <string-name><surname>Svetlov</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Kolb</surname> <given-names>VA</given-names></string-name>, <string-name><surname>Bogdanov</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Sergiev</surname> <given-names>PV</given-names></string-name>, <string-name><surname>Dontsova</surname> <given-names>OA</given-names></string-name></person-group>. <year>2012</year>. <article-title>Attenuation-based dual-fluorescent-protein reporter for screening translation inhibitors</article-title>. <source>Antimicrob Agents Chemother</source> <volume>56</volume>:<fpage>1774</fpage>–<lpage>1783</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.05395-11</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Page</surname> <given-names>R</given-names></string-name>, <string-name><surname>Peti</surname> <given-names>W</given-names></string-name></person-group>. <year>2016</year>. <article-title>Toxin-antitoxin systems in bacterial growth arrest and persistence</article-title>. <source>Nature Chemical Biology</source> <volume>12</volume>:<fpage>208</fpage>–<lpage>214</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.2044</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peters</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Mooney</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Grass</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Jessen</surname> <given-names>ED</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>F</given-names></string-name>, <string-name><surname>Landick</surname> <given-names>R</given-names></string-name></person-group>. <year>2012</year>. <article-title>Rho and NusG suppress pervasive antisense transcription in Escherichia coli</article-title>. <source>Genes &amp; development</source> <volume>26</volume>:<fpage>2621</fpage>–<lpage>33</lpage>. doi:<pub-id pub-id-type="doi">10.1101/gad.196741.112</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peters</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Mooney</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Kuan</surname> <given-names>PF</given-names></string-name>, <string-name><surname>Rowland</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Keles</surname> <given-names>S</given-names></string-name>, <string-name><surname>Landick</surname> <given-names>R</given-names></string-name></person-group>. <year>2009</year>. <article-title>Rho directs widespread termination of intragenic and stable RNA transcription</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>106</volume>:<fpage>15406</fpage>–<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0903846106</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ramu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vazquez-Laslop</surname> <given-names>N</given-names></string-name></person-group>. <year>2009</year>. <article-title>Programmed drug-dependent ribosome stalling: MicroReview</article-title>. <source>Molecular Microbiology</source> <volume>71</volume>:<fpage>811</fpage>–<lpage>824</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2008.06576.x</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Richardson</surname> <given-names>JP</given-names></string-name></person-group>. <year>2002</year>. <article-title>Rho-dependent termination and ATPases in transcript termination</article-title>. <source>Biochimica et biophysica acta</source> <volume>1577</volume>:<fpage>251</fpage>–<lpage>260</lpage>.</mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rivellini</surname> <given-names>F</given-names></string-name>, <string-name><surname>Alifano</surname> <given-names>P</given-names></string-name>, <string-name><surname>Piscitelli</surname> <given-names>C</given-names></string-name>, <string-name><surname>Blasi</surname> <given-names>V</given-names></string-name>, <string-name><surname>Bruni</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Carlomagno</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Brunt</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Carlomagno</surname> <given-names>MS</given-names></string-name></person-group>. <year>1991</year>. <article-title>A cytosine-over guanosine-rich sequence in RNA activates rho-dependent transcription termination</article-title>. <source>Molecular Microbiology</source> <volume>5</volume>:<fpage>3049</fpage>–<lpage>3054</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb01864.x</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samaha</surname> <given-names>RR</given-names></string-name>, <string-name><surname>Green</surname> <given-names>R</given-names></string-name>, <string-name><surname>Noller</surname> <given-names>HF</given-names></string-name></person-group>. <year>1995</year>. <article-title>A base pair between tRNA and 23S rRNA in the peptidyl transferase centre of the ribosome</article-title>. <source>Nature</source> <volume>377</volume>:<fpage>309</fpage>–<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1038/377309a0</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname> <given-names>D</given-names></string-name>, <string-name><surname>Gold</surname> <given-names>L</given-names></string-name>, <string-name><surname>Platt</surname> <given-names>T</given-names></string-name></person-group>. <year>1993</year>. <article-title>Selective Enrichment of Rna Species for Tight-Binding to Escherichia-Coli Rho-Factor</article-title>. <source>Faseb Journal</source> <volume>7</volume>:<fpage>201</fpage>–<lpage>207</lpage>.</mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schwartz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Walmacq</surname> <given-names>C</given-names></string-name>, <string-name><surname>Rahmouni</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Boudvillain</surname> <given-names>M</given-names></string-name></person-group>. <year>2007</year>. <article-title>Noncanonical interactions in the management of RNA structural blocks by the transcription termination rho helicase</article-title>. <source>Biochemistry</source> <volume>46</volume>:<fpage>9366</fpage>–<lpage>79</lpage>. doi:<pub-id pub-id-type="doi">10.1021/bi700493m</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seemann</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Gorodkin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Backofen</surname> <given-names>R</given-names></string-name></person-group>. <year>2008</year>. <article-title>Unifying evolutionary and thermodynamic information for RNA folding of multiple alignments</article-title>. <source>Nucleic Acids Res</source> <volume>36</volume>:<fpage>6355</fpage>–<lpage>6362</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkn544</pub-id></mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seemann</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Menzel</surname> <given-names>P</given-names></string-name>, <string-name><surname>Backofen</surname> <given-names>R</given-names></string-name>, <string-name><surname>Gorodkin</surname> <given-names>J</given-names></string-name></person-group>. <year>2011</year>. <article-title>The PETfold and PETcofold web servers for intra- and intermolecular structures of multiple RNA sequences</article-title>. <source>Nucleic Acids Res</source> <volume>39</volume>:<fpage>W107</fpage>–<lpage>111</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkr248</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seip</surname> <given-names>B</given-names></string-name>, <string-name><surname>Innis</surname> <given-names>CA</given-names></string-name></person-group>. <year>2016</year>. <article-title>How Widespread is Metabolite Sensing by Ribosome-Arresting Nascent Peptides?</article-title> <source>Journal of Molecular Biology</source> <volume>428</volume>:<fpage>2217</fpage>–<lpage>2227</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2016.04.019</pub-id></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shaw</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>N</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Lerner</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bittner</surname> <given-names>A</given-names></string-name>, <string-name><surname>Morrow</surname> <given-names>BJ</given-names></string-name></person-group>. <year>2003</year>. <article-title>Comparison of the changes in global gene expression of Escherichia coli induced by four bactericidal agents</article-title>. <source>J Mol Microbiol Biotechnol</source> <volume>5</volume>:<fpage>105</fpage>–<lpage>122</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000069981</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shong</surname> <given-names>J</given-names></string-name>, <string-name><surname>Collins</surname> <given-names>CH</given-names></string-name></person-group>. <year>2013</year>. <article-title>Engineering the esaR promoter for tunable quorum sensing-dependent gene expression</article-title>. <source>ACS synthetic biology</source> <volume>2</volume>:<fpage>568</fpage>–<lpage>75</lpage>. doi:<pub-id pub-id-type="doi">10.1021/sb4000433</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Bubunenko</surname> <given-names>M</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>C</given-names></string-name>, <string-name><surname>Abbott</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Stringer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Court</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2016</year>. <article-title>SuhB Associates with Nus Factors To Facilitate 30S Ribosome Biogenesis in Escherichia coli</article-title>. <source>mBio</source> <volume>7</volume>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00114-16</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname> <given-names>C</given-names></string-name>, <string-name><surname>Canestrari</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Champion</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Derbyshire</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Gray</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2022</year>. <article-title>Pervasive translation in Mycobacterium tuberculosis</article-title>. <source>eLife</source> <volume>11</volume>:<elocation-id>e73980</elocation-id>. doi:<pub-id pub-id-type="doi">10.7554/eLife.73980</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stringer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mangano</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2021</year>. <article-title>Identification of novel translated small ORFs in Escherichia coli using complementary ribosome profiling approaches</article-title>. <source>J Bacteriol</source> <fpage>JB0035221</fpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.00352-21</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stringer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Currenti</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bonocora</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Baranowski</surname> <given-names>C</given-names></string-name>, <string-name><surname>Petrone</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Palumbo</surname> <given-names>MJ</given-names></string-name>, <string-name><surname>Reilly</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Erill</surname> <given-names>I</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2014</year>. <article-title>Genome-scale analyses of Escherichia coli and Salmonella enterica AraC reveal noncanonical targets and an expanded core regulon</article-title>. <source>Journal of bacteriology</source> <volume>196</volume>:<fpage>660</fpage>–<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.01007-13</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stringer</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>N</given-names></string-name>, <string-name><surname>Yermakova</surname> <given-names>A</given-names></string-name>, <string-name><surname>Petrone</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Amarasinghe</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Reyes-Diaz</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mantis</surname> <given-names>NJ</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2012</year>. <article-title>FRUIT, a scar-free system for targeted chromosomal mutagenesis, epitope tagging, and promoter replacement in Escherichia coli and Salmonella enterica</article-title>. <source>PloS one</source> <volume>7</volume>:<fpage>e44841</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0044841</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Subramanian</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Ramu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2012</year>. <source>Inducible resistance to macrolide antibioticsAntibiotic Discovery and Development</source>. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>Springer US</publisher-name>. pp. <fpage>455</fpage>–<lpage>484</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4614-1400-1_13</pub-id></mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Suvorov</surname> <given-names>AN</given-names></string-name>, <string-name><surname>van Gemen</surname> <given-names>B</given-names></string-name>, <string-name><surname>van Knippenberg</surname> <given-names>PH.</given-names></string-name></person-group> <year>1988</year>. <article-title>Increased kasugamycin sensitivity in Escherichia coli caused by the presence of an inducible erythromycin resistance (erm) gene of Streptococcus pyogenes</article-title>. <source>Mol Gen Genet</source> <volume>215</volume>:<fpage>152</fpage>–<lpage>155</lpage>. doi:<pub-id pub-id-type="doi">10.1007/BF00331317</pub-id></mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takada</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mandell</surname> <given-names>ZF</given-names></string-name>, <string-name><surname>Yakhnin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Glazyrina</surname> <given-names>A</given-names></string-name>, <string-name><surname>Chiba</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kurata</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>KJY</given-names></string-name>, <string-name><surname>Tresco</surname> <given-names>BIC</given-names></string-name>, <string-name><surname>Myers</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Aktinson</surname> <given-names>GC</given-names></string-name>, <string-name><surname>Babitzke</surname> <given-names>P</given-names></string-name>, <string-name><surname>Hauryliuk</surname> <given-names>V</given-names></string-name></person-group>. <year>2022</year>. <article-title>Expression of Bacillus subtilis ABCF antibiotic resistance factor VmlR is regulated by RNA polymerase pausing, transcription attenuation, translation attenuation and (p)ppGpp</article-title>. <source>Nucleic Acids Res</source> <volume>50</volume>:<fpage>6174</fpage>–<lpage>6189</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkac497</pub-id></mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thomason</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Bischler</surname> <given-names>T</given-names></string-name>, <string-name><surname>Eisenbart</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Förstner</surname> <given-names>KU</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>A</given-names></string-name>, <string-name><surname>Herbig</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nieselt</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Storz</surname> <given-names>G</given-names></string-name></person-group>. <year>2015</year>. <article-title>Global Transcriptional Start Site Mapping Using Differential RNA Sequencing Reveals Novel Antisense RNAs in Escherichia coli</article-title>. <source>Journal of Bacteriology</source> <volume>197</volume>:<fpage>18</fpage>–<lpage>28</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.02096-14</pub-id></mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van der Stel</surname> <given-names>A-X</given-names></string-name>, <string-name><surname>Gordon</surname> <given-names>ER</given-names></string-name>, <string-name><surname>Sengupta</surname> <given-names>A</given-names></string-name>, <string-name><surname>Martínez</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Klepacki</surname> <given-names>D</given-names></string-name>, <string-name><surname>Perry</surname> <given-names>TN</given-names></string-name>, <string-name><surname>Herrero Del Valle</surname> <given-names>A</given-names></string-name>, <string-name><surname>Vázquez-Laslop</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sachs</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Cruz-Vera</surname> <given-names>LR</given-names></string-name>, <string-name><surname>Innis</surname> <given-names>CA.</given-names></string-name></person-group> <year>2021</year>. <article-title>Structural basis for the tryptophan sensitivity of TnaC-mediated ribosome stalling</article-title>. <source>Nat Commun</source> <volume>12</volume>:<fpage>5340</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41467-021-25663-8</pub-id></mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vázquez-Laslop</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2018a</year>. <article-title>Context-Specific Action of Ribosomal Antibiotics</article-title>. <source>Annual Review of Microbiology</source> <volume>72</volume>:<fpage>185</fpage>–<lpage>207</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-micro-090817-062329</pub-id></mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vázquez-Laslop</surname> <given-names>N</given-names></string-name>, <string-name><surname>Mankin</surname> <given-names>AS</given-names></string-name></person-group>. <year>2018b</year>. <article-title>How Macrolide Antibiotics Work</article-title>. <source>Trends Biochem Sci</source> <volume>43</volume>:<fpage>668</fpage>–<lpage>684</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.tibs.2018.06.011</pub-id></mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Venturini</surname> <given-names>E</given-names></string-name>, <string-name><surname>Svensson</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Maaß</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gelhausen</surname> <given-names>R</given-names></string-name>, <string-name><surname>Eggenhofer</surname> <given-names>F</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Cain</surname> <given-names>AK</given-names></string-name>, <string-name><surname>Parkhill</surname> <given-names>J</given-names></string-name>, <string-name><surname>Becher</surname> <given-names>D</given-names></string-name>, <string-name><surname>Backofen</surname> <given-names>R</given-names></string-name>, <string-name><surname>Barquist</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Westermann</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Vogel</surname> <given-names>J</given-names></string-name></person-group>. <year>2020</year>. <article-title>A global data-driven census of Salmonella small proteins and their potential functions in bacterial virulence</article-title>. <source>microLife</source> <volume>1</volume>. doi:<pub-id pub-id-type="doi">10.1093/femsml/uqaa002</pub-id></mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vimberg</surname> <given-names>V</given-names></string-name>, <string-name><surname>Cavanagh</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Novotna</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lenart</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nguyen Thi Ngoc</surname> <given-names>B</given-names></string-name>, <string-name><surname>Vesela</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pain</surname> <given-names>M</given-names></string-name>, <string-name><surname>Koberska</surname> <given-names>M</given-names></string-name>, <string-name><surname>Balikova Novotna</surname> <given-names>G.</given-names></string-name></person-group> <year>2020</year>. <article-title>Ribosome-Mediated Attenuation of vga(A) Expression Is Shaped by the Antibiotic Resistance Specificity of Vga(A) Protein Variants</article-title>. <source>Antimicrob Agents Chemother</source> <volume>64</volume>:<fpage>e00666</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00666-20</pub-id></mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Rennie</surname> <given-names>W</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Carmack</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Prévost</surname> <given-names>K</given-names></string-name>, <string-name><surname>Caron</surname> <given-names>M-P</given-names></string-name>, <string-name><surname>Massé</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ding</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wade</surname> <given-names>JT</given-names></string-name></person-group>. <year>2015</year>. <article-title>Identification of bacterial sRNA regulatory targets using ribosome profiling</article-title>. <source>Nucleic acids research</source> <volume>43</volume>:<fpage>10308</fpage>–<lpage>20</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1158</pub-id></mixed-citation></ref>
<ref id="c90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Rotman</surname> <given-names>ER</given-names></string-name>, <string-name><surname>Shoemaker</surname> <given-names>NB</given-names></string-name>, <string-name><surname>Salyers</surname> <given-names>AA</given-names></string-name></person-group>. <year>2005</year>. <article-title>Translational Control of Tetracycline Resistance and Conjugation in the Bacteroides Conjugative Transposon CTnDOT</article-title>. <source>Journal of Bacteriology</source> <volume>187</volume>:<fpage>2673</fpage>–<lpage>2680</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.187.8.2673-2680.2005</pub-id></mixed-citation></ref>
<ref id="c91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watters</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Abbott</surname> <given-names>TR</given-names></string-name>, <string-name><surname>Lucks</surname> <given-names>JB</given-names></string-name></person-group>. <year>2016a</year>. <article-title>Simultaneous characterization of cellular RNA structure and function with in-cell SHAPE-Seq</article-title>. <source>Nucleic Acids Research</source> <volume>44</volume>:<fpage>e12</fpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv879</pub-id></mixed-citation></ref>
<ref id="c92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watters</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Strobel</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Settle</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Lucks</surname> <given-names>JB</given-names></string-name></person-group>. <year>2016b</year>. <article-title>Characterizing RNA structures in vitro and in vivo with selective 2’-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq)</article-title>. <source>Methods</source> <volume>103</volume>:<fpage>34</fpage>–<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ymeth.2016.04.002</pub-id></mixed-citation></ref>
<ref id="c93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weaver</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mohammad</surname> <given-names>F</given-names></string-name>, <string-name><surname>Buskirk</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Storz</surname> <given-names>G</given-names></string-name></person-group>. <year>2019</year>. <article-title>Identifying Small Proteins by Ribosome Profiling with Stalled Initiation Complexes</article-title>. <source>mBio</source> <volume>10</volume>. doi:<pub-id pub-id-type="doi">10.1128/mBio.02819-18</pub-id></mixed-citation></ref>
<ref id="c94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yakhnin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Babiarz</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Yakhnin</surname> <given-names>AV</given-names></string-name>, <string-name><surname>Babitzke</surname> <given-names>P</given-names></string-name></person-group>. <year>2001</year>. <article-title>Expression of the Bacillus subtilis trpEDCFBA operon is influenced by translational coupling and Rho termination factor</article-title>. <source>J Bacteriol</source> <volume>183</volume>:<fpage>5918</fpage>–<lpage>5926</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JB.183.20.5918-5926.2001</pub-id></mixed-citation></ref>
<ref id="c95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yakhnin</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yakhnin</surname> <given-names>AV</given-names></string-name>, <string-name><surname>Mouery</surname> <given-names>BL</given-names></string-name>, <string-name><surname>Mandell</surname> <given-names>ZF</given-names></string-name>, <string-name><surname>Karbasiafshar</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kashlev</surname> <given-names>M</given-names></string-name>, <string-name><surname>Babitzke</surname> <given-names>P</given-names></string-name></person-group>. <year>2019</year>. <article-title>NusG-Dependent RNA Polymerase Pausing and Tylosin-Dependent Ribosome Stalling Are Required for Tylosin Resistance by Inducing 23S rRNA Methylation in Bacillus subtilis</article-title>. <source>mBio</source> <volume>10</volume>:<fpage>e02665</fpage>–<lpage>19</lpage>. doi:<pub-id pub-id-type="doi">10.1128/mBio.02665-19</pub-id></mixed-citation></ref>
<ref id="c96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamaguchi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Inouye</surname> <given-names>M</given-names></string-name></person-group>. <year>2015</year>. <article-title>An endogenous protein inhibitor, YjhX (TopAI), for topoisomerase i from Escherichia coli</article-title>. <source>Nucleic Acids Research</source> <volume>43</volume>:<fpage>10387</fpage>–<lpage>10396</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1197</pub-id></mixed-citation></ref>
<ref id="c97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yan</surname> <given-names>K</given-names></string-name>, <string-name><surname>Madden</surname> <given-names>L</given-names></string-name>, <string-name><surname>Choudhry</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Voigt</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Copeland</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Gontarek</surname> <given-names>RR</given-names></string-name></person-group>. <year>2006</year>. <article-title>Biochemical characterization of the interactions of the novel pleuromutilin derivative retapamulin with bacterial ribosomes</article-title>. <source>Antimicrobial Agents and Chemotherapy</source> <volume>65</volume>:<fpage>232</fpage>–<lpage>260</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00184-06</pub-id></mixed-citation></ref>
<ref id="c98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Xiao</surname> <given-names>T</given-names></string-name>, <string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>F</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>R</given-names></string-name>, <string-name><surname>Muhammad</surname> <given-names>I</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>X</given-names></string-name></person-group>. <year>2020</year>. <article-title>Wild-type cutoff for Apramycin against Escherichia coli</article-title>. <source>BMC Vet Res</source> <volume>16</volume>:<fpage>309</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12917-020-02522-0</pub-id></mixed-citation></ref>
<ref id="c99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zuker</surname> <given-names>M</given-names></string-name></person-group>. <year>2003</year>. <article-title>Mfold web server for nucleic acid folding and hybridization prediction</article-title>. <source>Nucleic acids research</source> <volume>31</volume>:<fpage>3406</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101217.2.sa4</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hinnebusch</surname>
<given-names>Alan G</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution>
</institution-wrap>
<city>Bethesda</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>In this <bold>important</bold> study, Baniulyte and Wade provide <bold>convincing</bold> evidence that translation of a short ORF denoted toiL positioned upstream of the topAI-yjhQP operon is responsive to different ribosome-targeting antibiotics, consequently controlling translation of the TopAI toxin as well as Rho-dependent transcription termination. Strengths of the study include combining a genetic screen to identify 23S rRNA mutations that affect topA1 expression and a creative approach to map the different locations of ribosome stalling within toiL induced by different antibiotics, with ribosome profiling and RNA structure probing by SHAPE to examine consequences of different antibiotics on toiL-mediated regulation. The work leaves unanswered how bacteria benefit by activating expression of the genes using the proposed strategy and the mechanism underlying ToiL's sensing of structurally distinct antibiotics.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101217.2.sa3</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The manuscript reports that expression of the E. coli operon topAI/yjhQ/yjhP is controlled by the translation status of a small open reading frame, that authors have discovered and named toiL, located in the leader region upstream of the operon. Authors propose the following model for topAI activation: Under normal conditions, toiL is translated but topAI is not expressed because of Rho-dependent transcription termination within the topAI ORF and because its ribosome binding site and start codon are trapped in an mRNA hairpin. Ribosome stalling at various codons of the toiL ORF, prompted in this work by some ribosome-targeting antibiotics, triggers an mRNA conformational switch which allows translation of topAI and, in addition, activation of the operon's transcription because presence of translating ribosomes at the topAI ORF blocks Rho from terminating transcription. The model is appealing and several of the experimental data mainly support it. However, it remains unanswered what is the true trigger of the translation arrest at toiL and what is the physiological role of the induced expression of the topAI/yjhQ/yjhP operon.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101217.2.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Baniulyte and Wade describe how translation of an 8-codon uORF denoted toiL upstream of the topAI-yjhQP operon is responsive to different ribosome-targeting antibiotics, consequently controlling translation of the TopAI toxin as well as Rho-dependent termination with the gene.</p>
<p>Strengths:</p>
<p>The authors used multiple different approaches such as a genetic screen to identify factors such as 23S rRNA mutations that affect topA1 expression and ribosome profiling to examine the consequences of various antibiotics on toiL-mediated regulation.</p>
<p>Weaknesses: Future experiments will be needed to better understand the physiological role of the toiL-mediated regulation and elucidate the mechanism of specific antibiotic sensing.</p>
<p>The results are clearly described, and the revisions have helped to improve the presentation of the data.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101217.2.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this revised manuscript, the authors provide convincing data to support an elegant model in which ribosome stalling by ToiL promotes downstream topAI translation and prevents premature Rho-dependent transcription termination. However, the physiological consequences of activating topAI-yjhQP expression upon exposure to various ribosome-targeting antibiotics remain unresolved. The authors have satisfactorily addressed all major concerns raised by the reviewers, particularly regarding the SHAPE-seq data. Overall, this study underscores the diversity of regulatory ribosome-stalling peptides in nature, highlighting ToiL's uniqueness in sensing multiple antibiotics and offering significant insights into bacterial gene regulation coordinated by transcription and translation.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.101217.2.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Baniulyte</surname>
<given-names>Gabriele</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wade</surname>
<given-names>Joseph T</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the original reviews</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>The manuscript reports that expression of the E. coli operon topAI/yjhQ/yjhP is controlled by the translation status of a small open reading frame, that authors have discovered and named toiL, located in the leader region of the operon. The authors propose the following model for topAI activation: Under normal conditions, toiL is translated but topAI is not expressed because of Rho-dependent transcription termination within the topAI ORF and because its ribosome binding site and start codon are trapped in an mRNA hairpin. Ribosome stalling at various codons of the toiL ORF, caused by the presence of some ribosome-targeting antibiotics, triggers an mRNA conformational switch which allows translation of topAI and, in addition, activation of the operon's transcription because the presence of translating ribosomes at the topAI ORF blocks Rho from terminating transcription. Even though the model is appealing and several of the experimental data support some aspects of it, several inconsistencies remain to be solved. In addition, even though TopAI was shown to be an inhibitor of topoisomerase I (Yamaguchi &amp; Inouye, 2015, NAR 43:10387), the authors suggest, without offering any experimental support, that, because ribosome-targeting antibiotics act as inducers, expression of the topAI/yjhQ/yjhP operon may confer resistance to these drugs.</p>
<p>Strengths:</p>
<p>- There is good experimental support of the transcriptional repression/activation switch aspect of the model, derived from well-designed transcriptional reporters and ChIP-qPCR approaches.</p>
<p>- There is a clever use of the topAI-lacZ reporter to find the 23S rRNA mutants where expression topAI was upregulated. This eventually led the authors to identify that translation events occurring at toiL are important to regulate the topAI/yjhQ/yjhP operon. Is there any published evidence that ribosomes with the identified mutations translate slowly (decreased fidelity does not necessarily mean slow translation, does it?)?</p>
</disp-quote>
<p>G2253 is in helix 80 of the 23S rRNA, which has been proposed to be involved in correct positioning of the tRNA. Mutations in helix 80 have been reported to cause defects in peptidyl transferase center activity, which could reduce the rate of ribosome movement along the mRNA. If ribosomes are sufficiently slowed when translating <italic>toiL</italic>, this could induce expression of <italic>topAI</italic>. G1911 and Ψ1917 are in helix 69 of the 23S rRNA, which is involved in forming the inter-subunit bridge, as well as interactions with release factors. Mutations in helix 69 cause a decrease in the processivity of translation, suggesting that the mutations we identified may increase the occupancy of ribosomes within <italic>toiL</italic>, thereby inducing expression of <italic>topAI</italic>. We have added text to the Discussion section to include this speculation.</p>
<disp-quote content-type="editor-comment">
<p>- Authors incorporate relevant links to the antibiotic-mediated expression regulation of bacterial resistance genes. Authors can also mention the tryptophan-mediated ribosome stalling at the tnaC leader ORF that activates the expression of tryptophan metabolism genes through blockage of Rho-mediated transcriptional attenuation.</p>
</disp-quote>
<p>We have added a citation to a recent structural study of ribosomes translating the <italic>tnaC</italic> uORF. Specifically, we speculate in the Discussion that <italic>toiL</italic> may have evolved to sense a ribosome-targeting antibiotic, or another ribosome-targeting small molecule such as an amino acid.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>The main weaknesses of the work are related to several experimental results that are not consistent with the model, or related to a lack of data that needs to be included to support the model.</p>
<p>The following are a few examples:</p>
<p>- It is surprising that authors do not mention that several published Ribo-seq data from E. coli cells show active translation of toiL (for example Li et al., 2014, Cell 157: 624). Therefore, it is hard to reconcile with the model that starts codon/Shine-Dalgarno mutations in the toiL-lux reporter have no effect on luciferase expression (Figure 2C, bar graphs of the no antibiotic control samples).</p>
</disp-quote>
<p>These data are for a <italic>topAI</italic>-lux reporter construct rather than <italic>toiL</italic>-lux. In our model, ribosome stalling within <italic>toiL</italic> is required to induce expression of the downstream genes; preventing translation of <italic>toiL</italic> by mutating the start codon or Shine-Dalgarno sequence would not cause ribosome stalling, consistent with the lack of an effect on <italic>topAI</italic> expression.</p>
<disp-quote content-type="editor-comment">
<p>- The SHAPE reactivity data shown in Figure 5A are not consistent with the toiL ORF being translated. In addition, it is difficult to visualize the effect of tetracycline on mRNA conformation with the representation used in Figure 5B. It would be better to show SHAPE reactivity without/with Tet (as shown in panel A of the figure).</p>
</disp-quote>
<p>We have modified this figure (now Figure 6) so that we no longer show the SHAPE-seq data +/- tetracycline overlayed on the predicted RNA structure, since at best, the predicted structure likely only represents uninduced state. We have included the predicted structure together with the SHAPE-seq data for untreated cells as a separate panel because it is part of the basis for our model. We have also added a supplementary figure showing a similar RNA structure prediction based on conservation of the <italic>topAI</italic> upstream region across species (Figure 6 – figure supplement 1), and we describe this in the text.</p>
<disp-quote content-type="editor-comment">
<p>- The &quot;increased coverage&quot; of topAI/yjhP/yjhQ in the presence of tetracycline from the Ribo-seq data shown in Figure 6A can be due to activation of translation, transcription, or both. For readers to know which of these possibilities apply, authors need to provide RNA-seq data and show the profiles of the topAI/yjhQ/yjhP genes in control/Tet-treated cells.</p>
</disp-quote>
<p>A previous study (Li <italic>et al</italic>., 2014, PMID 24766808) compared RNA-seq and Ribo-seq data for <italic>E. coli</italic> to measure normalized ribosome occupancy for each gene. However, sequence coverage for <italic>topAI</italic> was too low to confidently quantify either the RNA-seq or the Ribo-seq data. Presumably RNA levels were low because of Rho termination. Hence, we were not confident that RNA-seq would provide information on the regulation of <italic>topAI</italic>-<italic>yjhQP</italic>. Other data in our study provide strong evidence that regulation is primarily at the level of translation. And the key conclusion from Figure 6 (now Figure 7) is that tetracycline stalls ribosomes on start codons.</p>
<disp-quote content-type="editor-comment">
<p>- Similarly, to support the data of increased ribosomal footprints at the toiL start codon in the presence of Tet (Figure 6B), authors should show the profile of the toiL gene from control and Tet-treated cells.</p>
</disp-quote>
<p>Figure 6B shows data for both treated and untreated cells. The overall ribosome occupancy is much lower for untreated cells, making it difficult to draw strong conclusions about the relative distribution of ribosomes across <italic>toiL</italic>.</p>
<disp-quote content-type="editor-comment">
<p>- Representation of the mRNA structures in the model shown in Figure 5, does not help with visualizing 1) how ribosomes translate toiL since the ORF is trapped in double-stranded mRNA, and 2) how ribosome stalling on toiL would lead to the release of the initiation region of topAI to achieve expression activation.</p>
</disp-quote>
<p>We now show the predicted structure with only SHAPE-seq data for untreated cells. The comparison of SHAPE-seq +/- tetracycline is shown without reference to the predicted structure.</p>
<disp-quote content-type="editor-comment">
<p>- The authors speculate that, because ribosome-targeting antibiotics act as expression inducers [by the way, authors should mention and comment that, more than a decade ago, it had been reported that kanamycin (PMID: 12736533) and gentamycin (PMID: 19013277) are inducers of topAI and yjhQ], the genes of the topAI/yjhQ/yjhP operon may confer resistance to these antibiotics. Such a suggestion can be experimentally checked by simply testing whether strains lacking these genes have increased sensitivity to the antibiotic inducers.</p>
</disp-quote>
<p>We thank the reviewer for pointing out these references, which we now cite. The fact that another group found that gentamycin induces <italic>topAI</italic> expression – it is one of the most highly induced genes in that paper – strongly suggests that we missed the key inducing concentrations for one or more antibiotics, meaning that <italic>topAI</italic> is induced by even more ribosome-targeting antibiotics than we realized.</p>
<p>We did some preliminary experiments to look for effects of TopAI, YjhQ, and/or YjhP on antibiotic sensitivity, but generated only negative results. Since these experiments were preliminary and far from exhaustive, we have chosen not to include them in the manuscript. Other studies of genes regulated by ribosome stalling in a uORF have looked at genes whose functions in responding to translation stress were already known, so the environmental triggers were more obvious. With so many possible triggers for <italic>topAI</italic>-<italic>yjhQP</italic>, it will likely require considerable effort to find the relevant trigger(s). Hence, we consider this an important question, but beyond the scope of this manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this important study, Baniulyte and Wade describe how the translation of an 8-codon uORF denoted toiL upstream of the topAI-yjhQP operon is responsive to different ribosome-targeting antibiotics, consequently controlling translation of the TopAI toxin as well as Rho-dependent termination with the gene.</p>
<p>Strengths:</p>
<p>I appreciate that the authors used multiple different approaches such as a genetic screen to identify factors such as 23S rRNA mutations that affect topA1 expression and ribosome profiling to examine the consequences of various antibiotics on toiL-mediated regulation. The results are convincing and clearly described.</p>
<p>Weaknesses:</p>
<p>I have relatively minor suggestions for improving the manuscript. These mainly relate to the figures.</p>
<p><bold>Reviewer #3 (Public Review):</bold></p>
<p>Summary:</p>
<p>The authors nicely show that the translation and ribosome stalling within the ToiL uORF upstream of the co-transcribed topAI-yjhQ toxin-antitoxin genes unmask the topAI translational initiation site, thereby allowing ribosome loading and preventing premature Rho-dependent transcription termination in the topAI region. Although similar translational/transcriptional attenuation has been reported in other systems, the base pairing between the leader sequence and the repressed region by the long RNA looping is somehow unique in toiL-topAI-yjhQP. The experiments are solidly executed, and the manuscript is clear in most parts with areas that could be improved or better explained. The real impact of such a study is not easy to appreciate due to a lack of investigation on the physiological consequences of topAI-yjhQP activation upon antibiotic exposure (see details below).</p>
<p>Strengths:</p>
<p>Conclusion/model is supported by the integrated approaches consisting of genetics, in vivo SHAPE-seq and Ribo-Seq.</p>
<p>Provide an elegant example of cis-acting regulatory peptides to a growing list of functional small proteins in bacterial proteomes.</p>
<p><bold>Recommendations for the authors:</bold></p>
<p><bold>Reviewing Editor Comments:</bold></p>
<p>(1) Examine the consequences of mutations impeding translation of the topAI/yjhQ/yjhP operon on cell growth in the presence and absence of antibiotics.</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(2) Resolve discrepancies between the SHAPE data indicating constitutive sequestration of the toiL Shine Dalgarno sequence with antibiotic-regulated translation of the toiL ORF.</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(3) Reconcile published Ribo-Seq data with the model that start codon/Shine-Dalgarno mutations in the toiL-lux reporter have no effect on luciferase expression in the absence of antibiotics.</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(4) Clarify whether antibiotic MIC values were employed to select antibiotic concentrations for different experiments.</p>
</disp-quote>
<p>The antibiotic concentrations we used are in line with reported MICs for <italic>E. coli</italic>. We now list the reported ECOFFs/MICs and include relevant citations.</p>
<disp-quote content-type="editor-comment">
<p>(5) Provide RNA-seq data to complement the Ribo-Seq data for the topAI/yjhQ/yjhP genes in control vs. Tet-treated cells.</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(6) Revise the text to address as many of the reviewers' suggestions as reasonably possible.</p>
</disp-quote>
<p>Changes to the text have been made as indicated in the responses to the reviewers’ comments.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations for the Authors):</bold></p>
<p>(1) Page 6: I would have liked to have more information about the 39 suppressor mutations in rho. Do any of the cis-acting mutations give support for the model proposed in Figure 8?</p>
</disp-quote>
<p>We only know the specific mutation for some of the strains, and we now list those mutations in the Methods section. For other mutants, we mapped the mutation to either the <italic>rho</italic> gene or to Rho activity, but we did not sequence the <italic>rho</italic> gene. Most of the specific mutations we did identify fall within the primary RNA-binding site of Rho and hence should be considered partial-loss-of-function mutations (complete loss of function would be lethal).</p>
<p>We identified <italic>cis</italic>-acting mutations by re-transforming the <italic>lacZ</italic> reporter plasmid into a wild-type strain. We did not sequence any of these plasmids.</p>
<disp-quote content-type="editor-comment">
<p>(2) Page 12-13, Section entitled &quot;Mapping ribosome stalling sites induced by different antibiotics&quot;: This section should start with a better transition regarding the logic of why the experiments were carried out and should end with an interpretation of the results.</p>
</disp-quote>
<p>We have added a few sentences at the start of this section to explain the rationale. We have also added two sentences at the end of this section to summarize the interpretation of the data.</p>
<disp-quote content-type="editor-comment">
<p>(3) Page 15: The authors should discuss under what conditions the expression of TopAI (and YjhQ/YjhP might be induced? Is expression also elevated upon amino acid starvation?</p>
</disp-quote>
<p>We have looked through public RNA-seq data but have not identified growth conditions other than antibiotic treatment that induce expression of <italic>topAI</italic>, <italic>yjhQ</italic> or <italic>yjhP</italic>.</p>
<disp-quote content-type="editor-comment">
<p>(4) References: The authors should be consistent about capitalization, italics, and abbreviations in the references.</p>
</disp-quote>
<p>These formatting errors will be fixed in the proofing stage.</p>
<disp-quote content-type="editor-comment">
<p>(5) All graph figures: There should be more uniformity in the sizes of individual data points (some are almost impossible to see) and error bars across the figures.</p>
</disp-quote>
<p>We have tried to make the data points and error bars more visible for figures where they were smaller.</p>
<disp-quote content-type="editor-comment">
<p>(6) Figure 1B: I do not think the left arrow labeling is very intuitive and suggest renaming these constructs.</p>
</disp-quote>
<p>We have removed the arrows to improve clarity.</p>
<disp-quote content-type="editor-comment">
<p>(7) Figure 2A: toiL should be introduced at the first mention of Figure 2A.</p>
</disp-quote>
<p>We have added a schematic of the <italic>topAI</italic>-<italic>yjhQ</italic>-<italic>yjhP</italic> region as Figure 1A, including the <italic>toiL</italic> ORF, which we briefly mention in the text. We have opted to split Figure 2C into two panels. In Figure 2C we now only show data for the wild-type construct. Data for the mutant constructs are now shown in a new figure (Figure 5), alongside data for the wild-type constructs. We have simplified Figure 2A, since the mutations are not relevant to this revised figure, and we now show the schematic with the mutations as Figure 5A.</p>
<disp-quote content-type="editor-comment">
<p>(8) Figure 3C and 3D: I suggest giving these graphs headings (or changing the color of the bars in Figure 3D) to make it more obvious that different things are measured in the two panels.</p>
</disp-quote>
<p>We have added headers to panels B-D make it clear that which graphs show ChIP-qPCR data which graph shows qRT-PCR data.</p>
<disp-quote content-type="editor-comment">
<p>(9) Figure 6: It might be nice to show the topAI-yjhPQ operon here.</p>
</disp-quote>
<p>We now show the operon in Figure 1A.</p>
<disp-quote content-type="editor-comment">
<p>(10) Figure 8: This figure could be optimized by adding 5' and 3' end labels and having more similarity with the model in Figure 7.</p>
</disp-quote>
<p>The constructs shown in Figure 7 lack most of the <italic>topAI</italic> upstream region, so they aren’t readily comparable to the schematic in Figure 8. However, we have changed the color of the ribosome in Figure 7 to match that in Figure 8. We also indicate the 5’ end of the RNA in Figure 8.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Recommendations for the Authors):</bold></p>
<p>Areas to improve:</p>
<p>(1) While it's important to learn about ToiL-dependent regulation of the downstream topAI-yjhQ toxin-antitoxin genes, the physiological consequence of topAI-yjhQ activation seems to be lost in the manuscript. Everything was done with a reporter lacZ/lux. In the absence of toiL translation (i.e. SD mutant) and/or ribosome stalling, does premature transcription termination result in non-stochiometric synthesis of toxin vs. antitoxin, leading to growth arrest or other measurable phenotype? Knowing the impact of ToiL in the native topAI-yjhQ context will be valuable.</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(2) It was indicated in Figure 4-figure supplement 1 that toiL homologs are found in many other proteobacteria, are the UR sequences in those species also form a similar inhibitory RNA loop?? The nt sequence identity of toiL is likely to be constrained by the base pairing of the topAI 5' region.</p>
</disp-quote>
<p>We have added a supplementary figure panel showing an RNA structure prediction for the <italic>topAI</italic> upstream region based on sequence alignment of homologous regions from other species (Figure 6 – figure supplement 1).</p>
<disp-quote content-type="editor-comment">
<p>What is the frequency of the MLENVII hepta-peptide in the E. coli genome-wide. Is the sequence disfavored to avoid spurious multi-antibiotic sensing?</p>
</disp-quote>
<p>LENVII is not found in any annotated <italic>E. coli</italic> K-12 protein. However, this is a sufficiently long sequence that we would expect few to no instances in the <italic>E. coli</italic> proteome.</p>
<disp-quote content-type="editor-comment">
<p>(3) Figure 1A, it would be helpful to indicate the location of the toiL (red arrow as in Figure 2A) relative to the putative rut site early in the beginning of the results. Does TSS mark the transcription start site? There is no annotation of TSS in the figure legend. Was TSS previously mapped experimentally? Please include relevant citations.</p>
</disp-quote>
<p>We now indicate the position of the TSS relative to the <italic>topAI</italic> start codon. Similarly, we indicate the position of the start of <italic>toiL</italic> relative to the <italic>topAI</italic> start codon in Figure 2A. We now explain “TSS” in the figure legend. There is a reference in the text for the TSS (Thomason et al., 2015).</p>
<disp-quote content-type="editor-comment">
<p>(4) Please consider rearranging the results section, perhaps more helpful to introduce the toiL in Figure 1 or earlier. The current format requires readers to switch back-and-forth between Figure 4 and Figure 2.</p>
</disp-quote>
<p>We have added a schematic of the <italic>topAI</italic> upstream region as Figure 1A, and we have separated Figure 2C as described in a response to a comment from Reviewer 2.</p>
<disp-quote content-type="editor-comment">
<p>(5) Figure 2A and Figure 2-Figure Suppl 1A, for clarity, please mark the rut site upstream of the red arrow.</p>
</disp-quote>
<p>Rather than mark the <italic>rut</italic> on Figure 2A, which would make for a busy schematic, readers can compare the positions of the <italic>rut</italic> to those of <italic>toiL</italic>, which we have now added to Figures 1B (formerly Figure 1A) and 2A.</p>
<disp-quote content-type="editor-comment">
<p>(6) The following conclusion seems speculative: &quot;...but does not trigger termination until RNAP ..., &gt;180 nt further downstream…&quot;. Shouldn't the authors already know where the termination site is based on their previous Term-seq data (see Ref 1, Adams PP et al 2021)?</p>
</disp-quote>
<p>Sites of Rho-dependent transcription termination cannot be mapped precisely from Term-seq data because exoribonucleases rapidly process the unstructured RNA 3’ ends.</p>
<disp-quote content-type="editor-comment">
<p>(7) Genetic screen: Please discuss why the 23S rRNA mutations that cause translational infidelity could promote topAI translation. Wouldn't the mutant ribosome be affected in translating toiL?</p>
</disp-quote>
<p>See response to Reviewer 1’s comment.</p>
<disp-quote content-type="editor-comment">
<p>(8) Although antibiotic concentrations were provided in Figure 2 legend, please provide the MIC values of each antibiotic, e.g., in Table S2, for the tested E. coli strain, to inform readers how specific subinhibitory concentrations were chosen.</p>
</disp-quote>
<p>See response to Reviewing Editor.</p>
<disp-quote content-type="editor-comment">
<p>(9) Please clarify the calculation of luciferase units in the y-axis of Figure 2A, why the scale is drastically higher than that of Figure 7C using the same antibiotics?</p>
</disp-quote>
<p>These reporter assays use different constructs. The reporter construct used for experiments in Figure 7 includes a portion of the <italic>ermCL</italic> gene and associated downstream sequence. We have enlarged Figure 7A to highlight the difference in reporter constructs.</p>
<disp-quote content-type="editor-comment">
<p>(10) Table S4 needs a few more details. It is unclear how those numbers in columns G-H were generated. Do those numbers correspond to ribosome density per nt/ORF?</p>
</disp-quote>
<p>We have added footnotes to Table S4 to indicate that the numbers in columns G and H represent sequence read coverage normalized by region length and by the upper quartile of gene expression.</p>
<disp-quote content-type="editor-comment">
<p>(11) Figure 5, if the SHAPE results were true, the Shine Dalgarno sequence of toiL is sequestered in the hairpin structure with and without tetracycline treatment. It is inconceivable that translational initiation will occur efficiently, please discuss.</p>
</disp-quote>
<p>Our representation of the SHAPE-seq data was confusing since we overlayed the SHAPE-seq changes on a predicted structure that likely corresponds to the uninduced state. We hope that the new version of Figure 5 is clearer.</p>
<p>We presume the reviewer is referring to the Shine-Dalgarno sequence of <italic>topAI</italic> rather than <italic>toiL</italic>, since the Shine-Dalgarno sequence of <italic>toiL</italic> is predicted to be unstructured even in the absence of tetracycline treatment. The ribosome-binding site of <italic>topAI</italic> is more accessible in cells treated with tetracycline, although the SHAPE-seq data suggest that this is a transient event. The binding of the initiating ribosome may also reduce reactivity in this region under inducing conditions. We now discuss this briefly in the text.</p>
</body>
</sub-article>
</article>